Document:

Exhibit 10.6

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (the “Agreement”)
dated October 23, 2015, effective as of October 1, 2015, between BST Distribution, Inc., a New York corporation (“BST”),
We Sell Cellular, LLC, a Delaware limited liability company (“We Sell”), (BST and We Sell, together, the “Company”)
and Scott Tepfer (the “Executive”). The Executive acknowledges that while We Sell primarily carries on the business
operated by the Company, BST conducts certain business for the Company. Accordingly, references to needing the consent of the Manager
of We Sell apply for any business conducted by the Company.

 

WHEREAS, in its business,
the Company has acquired and developed certain trade secrets, including, but not limited to, proprietary processes, sales methods
and techniques, and other like confidential business and technical information, including but not limited to, technical information,
design systems, pricing methods, pricing rates or discounts, processes, procedures, formulas, designs of computer software, or
improvements, or any portion or phase thereof, whether patented, or not, or unpatentable, that is of any value whatsoever to the
Company, as well as information relating to the Company’s products, information concerning proposed new products, market
feasibility studies, proposed or existing marketing techniques or plans (whether developed or produced by the Company or by any
other person or entity for the Company), and other Confidential Information, as defined in Section 8(a), which necessarily will
be communicated to the Executive by reason of his employment by the Company; and

 

WHEREAS, the Company
has strong and legitimate business interests in preserving and protecting its investment in the Executive, its trade secrets and
Confidential Information, and its substantial, significant, or key, relationships with vendors, and Customers, as defined below,
whether actual or prospective; and

 

WHEREAS, the Company
desires to preserve and protect its legitimate business interests further by restricting competitive activities of the Executive
during the term of this Agreement and for a reasonable time following the termination of this Agreement; and

 

WHEREAS, the Company
desires to employ the Executive and to ensure the continued availability to the Company of the Executive’s services, and
the Executive is willing to accept such employment and render such services, all upon and subject to the terms and conditions contained
in this Agreement.

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants set forth in this Agreement, and intending to be legally bound, the Company
and the Executive agree as follows:

 

1.           Representations
and Warranties. The Executive hereby represents and warrants to the Company that he (i) is not subject to any written non-solicitation
or non-competition agreement affecting his employment with the Company (other than any prior agreement with the Company), (ii)
is not subject to any written confidentiality or nonuse/nondisclosure agreement affecting his employment with the Company (other
than any prior agreement with the Company), and (iii) has brought to the Company no trade secrets, confidential business information,
documents, or other personal property of a prior employer.

 

    	 	1	 

     

    

 

2.           Term
of Employment.

 

(a)          Term.
The Company hereby employs the Executive, and the Executive hereby accepts employment with the Company for a period of commencing
as of the date of this Agreement until December 31, 2018 (the “Term”). The Term will be automatically extended for
additional one-year periods unless either party gives notice to the other, at least sixty (60) days prior to the then current expiration
date, of that party’s intention not to renew this Agreement.

 

(b)          Continuing
Effect. Notwithstanding any termination of this Agreement, at the end of the Term or otherwise, the provisions of Sections
7 and 8 shall remain in full force and effect and the provisions of Section 8 shall be binding upon the legal representatives,
successors and assigns of the Executive.

 

3.           Duties.

 

(a)          General
Duties. The Executive shall serve as the President of the Company, with duties and responsibilities that are customary for
such executives. The Executive shall also perform services for such subsidiaries of the Company as may be necessary and for its
Parent (as defined below) as may be agreed by the Parent and the Executive. The Executive shall use his best efforts to perform
his duties and discharge his responsibilities pursuant to this Agreement competently, carefully and faithfully. In determining
whether or not the Executive has used his best efforts hereunder, the Executive’s and the Company’s delegation of authority
and all surrounding circumstances shall be taken into account and the best efforts of the Executive shall not be judged solely
on the Company’s earnings or other results of the Executive’s performance, except as specifically provided to the contrary
by this Agreement.

 

(b)          Devotion
of Time. Subject to the last sentence of this Section 3(b), the Executive shall devote all of his time, attention and energies
during normal business hours (exclusive of periods of sickness and disability and of such normal holiday and vacation periods as
have been established by the Company) to the affairs of the Company. The Executive shall not enter the employ of or serve as a
consultant to, or in any way perform any services with or without compensation to, any other person, business, or organization,
without the prior consent of the manager of the Company (the “Manager”). Notwithstanding the above, the Executive shall
be permitted (i) to devote a limited amount of his time, without compensation, to professional, community, charitable or similar
organizations, (ii) to devote such time as he deems necessary or advisable to the litigation with Samsung Electronics America,
Inc. f/k/a Samsung Telecommunications America, LLC (including any related actions and any appeals) (the “Samsung Litigation”),
it being acknowledged that the Company’s rights in the Samsung Litigation have been assigned to the Executive and the other
former owner of the Company (collectively, the “Prior Owners”), and (iii) to own up to fifty percent (50%) of TLT Innovations
LLC (“TLT”) and spend a limited amount of time overseeing the TLT business and his investment in TLT as long as such
activities do not adversely affect the performance of his obligations to the Company.

 

    	 	2	 

     

    

 

(c)          Location
of Office. The Executive’s principal business office shall be at the Company’s West Babylon, New York offices.
However, the Executive’s job responsibilities shall include all business travel necessary to the performance of his job.

 

(d)          Adherence
to Inside Information Policies. The Executive acknowledges that the Company’s parent, uSell.com, Inc. (the “Parent”)
is publicly-held and, as a result, has implemented inside information policies designed to preclude its executives and those of
its subsidiaries from violating the federal securities laws by trading on material, non-public information or passing such information
on to others in breach of any duty owed to the Company, or any third party. The Executive shall promptly execute any agreements
generally distributed by the Parent to its employees requiring such employees to abide by its inside information policies.

 

4.           Compensation
and Expenses.

 

(a)          Salary.
For the services of the Executive to be rendered under this Agreement, the Company shall pay the Executive an annual salary of
$500,000 (the “Base Salary”) payable in accordance with the Company’s normal payroll practices. Payment of Base
Salary may be made by either BST or We Sell but all computations of EBITDA shall be on a combined basis. The Company’s earnings
before interest, taxes, depreciation and amortization (“EBITDA”) shall be based upon the net income (loss) of the Company
determined in accordance with United States Generally Accepted Accounting Principles, consistently applied, beginning on the date
of this Agreement (the “Inception Date”) and measured against the EBITDA targets (each, an “EBITDA Target”)
and EBITDA thresholds (each, an “EBITDA Threshold”) set forth on Schedule 4(a)(1)(A) hereto. Schedule 4(a)(1)(B)
applies only for the Bonus calculations through June 30, 2016 as described in Section 4(b) below. If the Company’s EBITDA
for any of the six-month periods beginning January 1, 2016 (each, a “Measuring Period”), is below the EBITDA Threshold
for such Measuring Period, the Base Salary shall be reduced for the current Measuring Period until the first day of the next Measuring
Period to the “Adjusted Base Salary” determined using the formulas attached as Schedules 4(a)(2) and 4(a)(3),
provided, however, the Base Salary shall not be reduced below $360,000 annually or $30,000 per month. Any Adjusted
Base Salary shall be effective retroactively to the inception of the current Measuring Period and remain in effect for the six-month
period ending on the last day of the current Measuring Period. For purposes of this Section 4(a) and Section 4(b) below, the Company
shall calculate EBITDA as of the end of each Measuring Period and shall deliver such EBITDA calculation to the Executive within
forty five (45) days after the end of the Measuring Period. The Adjusted Base Salary will be revised after the six month Measuring
Period ending December 31, 2016 and thereafter after each six month Measuring Period. The Company and the Executive understand
that the future EBITDA Target for the three months ending December 31, 2018 has not been forecasted. Accordingly, they shall negotiate
the EBITDA Target for such period and Schedule 4(a)(1)(A) shall be modified. In the event of any disagreement, the Board of Directors
of the Parent shall determine the EBITDA Target for such period.

 

    	 	3	 

     

    

 

(b)          Bonus.
If the Company’s EBITDA for a Measuring Period equals the EBITDA Target for such Measuring Period, the Executive shall receive
a bonus (the “Bonus”) in the amount of $250,000 (the “Bonus Target”), except for the three-month Bonus
Measuring Period ending June 30, 2016, for which the Bonus Target will be $125,000. Schedule 4(a)(1)(A) reflects the Bonus
calculations for all periods beginning July 1, 2016 and Schedule 4(a)(1)(B) reflects the Bonus calculations for the initial
periods from October 1, 2015 through March 31, 2016 and April 1, 2016 through June 30, 2016. If the Company’s EBITDA for
a Measuring Period exceeds the EBITDA Target for such Measuring Period, the Executive shall receive a Bonus which exceeds the Bonus
Target by the proportion by which the actual EBITDA exceeds the EBITDA Target. By way of example, if actual EBITDA for a Measuring
Period is 120% of the EBITDA Target, the Bonus will be 120% of the Bonus Target, or $300,000. If the Company’s EBITDA for
a Measuring Period is less than the EBITDA Target for such Measuring Period but is between 100% and 150% of the EBITDA Threshold
for such Measuring Period, the Executive shall receive a Bonus determined using the formula in Schedule 4(b)(1). To the
extent that the actual EBITDA for a Measuring Period is less that the EBITDA Target but more than 150% of the EBITDA Threshold,
the Executive shall receive an additional Bonus calculated as reflected on Schedule 4(b)(2). Any Bonuses under Sections
4(b) and 4(c) will be paid to the Executive by the Company within five (5) days after the Company’s delivery of the applicable
EBITDA calculation, but in any event within forty five (45) days after the end of the applicable Measuring Period ending on March
31 or June 30, and ninety (90) days after the end of a Measuring Period ending on December 31st.

 

(c)          Audited
EBITDA; Review by Executive. As of each December 31st during the Term beginning with December 31 2016, the Company
shall have its registered independent public accounting firm audit its EBITDA for the 12 month period then ended (the “Audited
EBITDA”). The Audited EBITDA shall be used to recalculate the Adjusted Base Salary and Bonus. If the recalculated Adjusted
Base Salary is higher and/or the recalculated Bonus is greater than the original calculation, respectively, the Company hereby
agrees to pay the difference to the Executive within 10 business days after such recalculation. Further, if the recalculated Adjusted
Base Salary is lower and/or the recalculated Bonus is lower than the original calculation, respectively, the Executive hereby agrees
to pay the difference to the Company within 10 business days. The Company will permit the Executive and his representatives to
review the books and records and other relevant data of the Company specifically relating to the calculation of EBITDA, the Adjusted
Base Salary and the Bonus.

 

(d)          Expenses.
In addition to any compensation received pursuant to this Section 4, the Company will reimburse or advance funds to the Executive
for all reasonable travel, entertainment and miscellaneous expenses incurred in connection with the performance of his duties
under this Agreement, provided that the Executive properly provides a written accounting of such expenses to the Company in accordance
with the Company’s practices. Such reimbursement or advances will be made in accordance with policies and procedures of
the Company in effect from time to time relating to reimbursement of, or advances to, its executive officers. Without limiting
the generality of the foregoing, the Company will reimburse or advance to the Executive (i) the cost of leasing up to one automobile
(not to exceed $1,000 per month) and related expenses (including gas, insurance and automobile maintenance and repairs) in a reasonable
amount consistent with the Company’s practice prior to the date of this Agreement, (ii) a cell phone and cell phone voice
and data plan, and (iii) home office FiOS or similar Internet service. Upon any termination
of this Agreement, the Company shall reimburse the Executive for any expenses incurred prior to the effective date of termination
in accordance with this Section 4. The Executive may continue to use his personal credit cards to purchase inventory to be titled
in the name of the Company, and the Company will reimburse, indemnify, and hold the Executive harmless for all such purchases.
All proceeds from the sale of such inventory shall be delivered to the Company.

 

    	 	4	 

     

    

 

(e)          Failure
to Pay Salary and Bonuses; Right to Cure. The Executive shall be an authorized signer on all banking and money market accounts
of the Company and will have the ability and the duty to make any payments to himself. In the event that the Company lacks sufficient
money to make any payments of salary and/or bonus, the Executive shall give notice to the Company, which shall have 30 days to
cure the non-payment. Pending the 30 day cure period, the Executive shall have no rights to enforce this Agreement by filing an
action in Court against the Company for non-payment. If the Company fails to cure the non-payment after the 30-day cure period
has expired, the non-competition provisions set forth in Section 7 of this Agreement shall not be enforceable against the Executive,
and the Executive may take any legal action to enforce this Agreement and may exercise any and all other rights available to him.

 

5.           
Employee Benefit Programs; D&O Insurance.

 

(a)          The
Executive is entitled to participate in any pension, 401(k), insurance or other employee benefit plan that is maintained by the
Company for its executives, including programs of life and medical insurance and reimbursement of membership fees in professional
organizations. Without limiting the generality of the foregoing, the Company will pay or reimburse the Executive for health care
continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA) related to his employment prior to the date
of this Agreement or for employee co-payments for health insurance, as the case may be. Upon any termination of this Agreement,
the Executive will be entitled to any benefits accrued under any applicable benefit plans and programs of the Company.

 

(b)          The
Company will provide and maintain, directly or through the Parent, a D&O liability insurance policy covering the Executive
in his capacity as an officer, director and/or manager of the Parent and any of its affiliates (including the Company) until such
time as actions against the Executive are no longer permitted by law but for at least six years after the termination of Executive’s
service as officer, director or manager, with terms and conditions no less favorable (including, without limitation, with respect
to scope, exclusions, amounts and deductibles) than the most favorable coverage then applying to any current or future senior level
executive officer or director of the Parent, provided that such coverage is no less favorable than the D&O liability coverage
in effect for the Parent’s officers and directors on the date hereof. The Company agrees to provide the Executive with evidence
of such coverage upon his request.

 

    	 	5	 

     

    

 

6.            Termination.

 

(a)          Death
or Disability. Except as otherwise provided in this Agreement, this Agreement shall automatically terminate upon the death
or disability of the Executive. For purposes of this Section 6(a), “disability” shall mean (i) the Executive is unable
to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be
expected to result in death, or last for a continuous period of not less than 12 months; (ii) the Executive is, by reason
of any medically determinable physical or mental impairment that can be expected to result in death, or last for a continuous period
of not less than 12 months, receiving income replacement benefits for a period of not less than three  months under an
accident and health plan covering employees of the Company; or (iii) the Executive is determined to be totally disabled by
the Social Security Administration. Any question as to the existence of a disability shall be determined by the written opinion
of the Executive’s regularly attending physician (or his guardian) (or the Social Security Administration, where applicable).
In the event of the death of the Executive, the Executive’s estate shall receive any unpaid, earned compensation and benefits
due the Executive and this Agreement shall terminate. In the event that the Executive’s employment is terminated by reason
of Executive’s death or disability, the Company shall pay the following to the Executive or his estate: (i) any accrued but
unpaid Base Salary for services rendered to the date of termination, (ii) any accrued but unpaid expenses required to be reimbursed
under this Agreement, (iii) any earned but unpaid Bonus for any Measuring Period ended prior to the date of termination, and (iv)
any earned but unpaid Bonus for the Measuring Period in which the death or disability occurs (to the extent it can be calculated).
The Executive (or his estate) shall receive the payments provided herein at such times he would have received them if there was
no death or disability. Additionally, if the Executive’s employment is terminated because of disability, any benefits to
which the Executive may be entitled pursuant to Section 5(a) hereof shall continue to be paid or provided by the Company for one
year following the date of termination.         

 

(b)          
Termination by the Company for Cause or by the Executive Without Good Reason. The Company may terminate the Executive’s
employment pursuant to the terms of this Agreement at any time for Cause (as defined below) by giving the Executive written notice
of termination. Such termination shall become effective upon the giving of such notice. Upon any such termination for Cause, or
in the event the Executive terminates his employment with the Company without “Good Reason,” as defined below, or the
Executive elects not to renew this Agreement under Section 2(a) upon the termination of the initial Term or any extension thereof,
then the Executive shall have no right to compensation, or reimbursement of expenses under Section 4(d), or to participate in any
Executive benefit programs under Section 5(a), except as may otherwise be provided for herein or by law, for any period subsequent
to the effective date of termination. For purposes of this Agreement, “Cause” shall mean: (i) the Executive is convicted
of a felony involving (A) dishonesty or fraud relating to the business of the Company, the
Parent or any of their affiliates, or (B) the embezzlement of funds or property of any person or entity, including the Company,
the Parent or any of their affiliates; (ii) the Executive, in carrying out his duties hereunder, has been found in a civil action
to have committed gross negligence or intentional misconduct resulting, in either case, in material harm to the Company; (iii)
the Executive becomes subject to a preliminary or permanent injunction issued by a United States District Court enjoining the Executive
from violating any securities law administered or regulated by the Securities and Exchange Commission (the “SEC”);
(iv) the Executive becomes subject to a cease and desist order or other order issued by the SEC after an opportunity for a hearing;
(v) the Executive has been found in a civil action to have materially breached any provision of Section 7 and/or Section 8 and
to have thereby caused material harm to the Company; or (vi) the Company has been required to restate any of its financial statements
filed with the SEC as a result of the Executive’s gross negligence or willful misconduct. 

 

    	 	6	 

     

    

 

(c)          Termination
by the Executive for Good Reason or by the Company without Cause. The Executive may terminate this Agreement for Good Reason
(as defined below). In the event the Executive terminates this Agreement for Good Reason, the Company terminates the Executive’s
employment without Cause or the Company elects not to renew this Agreement under Section 2(a) upon the termination of the initial
Term or any extension thereof, the Executive shall be entitled to the following: (i) any accrued but unpaid Base Salary through
the termination date, (ii) an amount equal to the Executive’s Base Salary for the remainder of the Term, but no less than
twelve months’ Base Salary; (iii) any accrued but unpaid expenses required to be reimbursed under this Agreement; (iv) any
earned but unpaid Bonus for any Measuring Period ended prior to the date of termination; and (v) any earned but unpaid Bonus for
the Measuring Period in which termination occurs (to the extent it can be calculated). The term “Good Reason” shall
mean: (i) a change in the Executive’s title or a diminution in the Executive’s authority, duties or responsibilities
(unless the Executive has agreed to such change or diminution); (ii) any reduction in compensation or material reduction in benefits
of the Executive (unless the Executive has agreed to such reduction or as otherwise provided in this Agreement); (iii) the relocation
of the Company’s offices more than ten (10) miles from their current location in West Babylon, New York (unless the Executive
has agreed to such relocation); or (iv) any other action or inaction that constitutes a material breach by the Company under this
Agreement, it being understood that the Company’s failure to make any payments due under Section 4 is a material breach hereunder.
Prior to the Executive terminating his employment with the Company for Good Reason, Executive must provide written notice to the
Company, within 90 days following the initial existence of such condition, that such Good Reason exists, setting forth in detail
the grounds the Executive believes constitute Good Reason. If the Company does not cure the condition(s) constituting Good Reason
within 30 days following receipt of such notice, then the Executive’s employment shall be deemed terminated for Good Reason.
The Executive shall receive the payments provided herein at such times he would have received them if there was no termination.

 

7.            Non-Competition
Agreement.

 

(a)          Competition
with the Company. Until termination of his employment and for a period of 12 months commencing on the date of termination (the
“Restricted Period”), the Executive (individually or in association with, or as a shareholder, director, officer, consultant,
employee, partner, joint venturer, member, or otherwise, of or through any person, firm, corporation, partnership, association
or other entity) shall not, directly or indirectly, compete with the Company (which for the purpose of this Section 7 also includes
the Parent) by acting as an officer (or comparable position) of, owning an interest in, or providing services to any entity within
any metropolitan area in the United States or other country in which the Company was actually engaged in business as of the time
of termination of employment or where the Company reasonably expected to engage in business within three months of the date of
termination of employment. For purposes of this Agreement, the term “compete with the Company” shall refer to any business
activity in which the Company was engaged as of the termination of the Executive’s employment or reasonably expected to engage
in within three months of termination of employment (the “Prohibited Business”). The Executive shall not be deemed
to have breached this Section 7(a) by (i) owning less than 5% of any class of securities of any entity which files reports with
the SEC so long as the Executive does not engage in the operation, management or control of such entity, (ii) participating in
the Samsung Litigation or (iii) owning less than 50% of TLT or participating in the business of TLT (which participation may be
active and substantial after the termination of the Executive’s employment with the Company).

 

    	 	7	 

     

    

 

(b)          Solicitation
of Customers. During the Restricted Period, the Executive, directly or indirectly, will not seek nor accept Prohibited Business
from any Customer (as defined below) on behalf of any enterprise or business other than the Company, refer Prohibited Business
from any Customer to any enterprise or business other than the Company or receive commissions based on sales or otherwise relating
to the Prohibited Business from any Customer. For purposes of this Section 7(b), the term “Customer” means (i) any
cellular or mobile phone company, (ii) any marketing company that offers consumers cellular or mobile phone service through an
arrangement with a cellular or mobile company, or (iii) any retail business that sells cellular or mobile phones.

 

(c)          Solicitation
of Employees. During the Restricted Period, the Executive agrees that he shall not, directly or indirectly, request, recommend
or advise any employee of the Company or the Parent to terminate his or her employment with the Company or the Parent, or solicit
for employment or recommend to any third party the solicitation for employment of any person who, at the time of such solicitation,
is employed by the Company, the Parent or any of their respective subsidiaries and affiliates.

 

(d)          Early
Termination of the Restricted Period. Notwithstanding the foregoing, if the Executive is terminated by the Company other than
for Cause or resigns for Good Reason or if the Company elects not to renew this Agreement under Section 2(a) at the end of the
initial Term or any extension thereof, the Restricted Period will end. In addition, the Restricted Period will end if the Parent
fails to meet the conditions of Section 7.4(a) of the Stock Purchase Agreement, dated as of the date hereof, between the Parent,
BST and the Prior Owners (the “SPA”) and the Prior Owners have not succeeded in selling a total of at least $6,000,000
of the Parent’s common stock under Section 7.4(b) of the SPA by the date 30 days following the earlier of (i) the filing
of the Parent’s annual report with the SEC for the year ended December 31, 2016 and (ii) the SEC’s filing deadline
for the filing of the Parent’s annual report with the SEC for the year ended December 31, 2016; provided, however, that the
Company and the Parent shall have three (3) months to cure the failure of the Prior Owners to receive a total of $6,000,000 in
gross proceeds.

 

(e)          No
Payment. The Executive acknowledges and agrees that no separate or additional payment will be required to be made to him in
consideration of his undertakings in this Section 7, and confirms he has received adequate consideration for such undertakings.

 

(f)          References.
References to the Company in this Section 7 shall include the Company’s subsidiaries and affiliates.

 

    	 	8	 

     

    

  

8.            Non-Disclosure
of Confidential Information.

 

(a)          Confidential
Information. For purposes of this Agreement, “Confidential Information” includes, but is not limited to, trade
secrets, processes, policies, procedures, techniques, designs, drawings, know-how, show-how, technical information, specifications,
computer software and source code, information and data relating to the development, research, testing, costs, marketing, and uses
of the Products (as defined herein), the Company’s budgets and strategic plans, and the identity and special needs of the
Company’s customers, vendors, and suppliers, databases, data, and all technology relating to the Company’s businesses,
systems, methods of operation, and customer lists and other customer information, solicitation leads, marketing and advertising
materials, methods and manuals and forms, all of which pertain to the activities or operations of the Company and unless the Restricted
Period has expired or ended early under Section 7(d), the names, home addresses and all telephone numbers and e-mail addresses
of the Company’s directors, employees, officers, executives, former executives, Customers and former Customers and the identity
of and telephone numbers, e-mail addresses and other addresses of executives or agents of Customers and former Customers who are
the persons with whom the Company’s executives, officers, employees, and agents communicate in the ordinary course of business.
Confidential Information also includes, without limitation, Confidential Information received from the Parent and its subsidiaries
and affiliates. For purposes of this Agreement, the following will not constitute Confidential Information (i) information which
is or subsequently becomes generally available to the public or to persons operating in the same industry as the Company through
no act of the Executive in violation of this Agreement, (ii) information set forth in the written records of the Executive prior
to disclosure to the Executive by or on behalf of the Company, and (iii) information which is lawfully obtained by the Executive
in writing from a third party (excluding any affiliates of the Executive) who lawfully acquired the confidential information and
who did not acquire such confidential information or trade secret, directly or indirectly, from the Executive or the Company or
its Parent, subsidiaries or affiliates and who has not breached any duty of confidentiality to the Company or its Parent, subsidiaries
or affiliates. As used herein, the term “Products” shall include all products offered for sale and marketed by the
Company during the Term and any other products which the Company has taken concrete steps to offer for sale, but has not yet commenced
marketing, during or prior to the Term. Products also include any products disclosed in the Parent’s latest Form 10-K and/or
Form S-1 or S-3 (or successor form) filed with the SEC.

 

(b)          Legitimate
Business Interests. The Executive recognizes that the Company has legitimate business interests to protect and as a consequence,
the Executive agrees to the restrictions contained in this Agreement because they further the Company’s legitimate business
interests. These legitimate business interests include, but are not limited to (i) trade secrets, (ii) valuable confidential business,
technical, and/or professional information that otherwise may not qualify as trade secrets, including, but not limited to, all
Confidential Information; (iii) substantial, significant, or key, relationships with specific prospective or existing customers,
vendors or suppliers; (iv) customer goodwill associated with the Company’s business; and (v) specialized training relating
to the Company’s technology, Products, methods, operations and procedures.

 

(c)          Confidentiality.
Following termination of employment, the Confidential Information shall be held by the Executive in confidence and shall not, without
the prior express written consent of the Company, be disclosed to any person other than in connection with the Executive’s
employment by the Company. The Executive further acknowledges that such Confidential Information as is acquired and used by the
Company or its Parent and subsidiaries or affiliates is a special, valuable and unique asset. The Executive shall exercise all
due and diligent precautions to protect the integrity of the Company’s Confidential Information and to keep it confidential
whether it is in written form, on electronic media, oral, or otherwise. The Executive shall not copy any Confidential Information
except to the extent necessary to his employment nor remove any Confidential Information or copies thereof from the Company’s
premises except to the extent necessary to his employment. All records, files, materials and other Confidential Information obtained
by the Executive in the course of his employment with the Company are confidential and proprietary and shall remain the exclusive
property of the Company or its customers, as the case may be. The Executive shall not, except in connection with and as required
by his performance of his duties under this Agreement, for any reason use for his own benefit or the benefit of any person or entity
with which he may be associated or disclose any such Confidential Information to any person, firm, corporation, association or
other entity for any reason or purpose whatsoever without the prior express written consent of the Manager of We Sell. 
The Executive’s obligations of confidentiality under this Section 8 will remain in effect for
a period of three years after termination of the Executive’s employment. 

 

    	 	9	 

     

    

 

9.            Equitable
Relief.

 

(a)          The
Company and the Executive recognize that the services to be rendered under this Agreement by the Executive are special, unique
and of extraordinary character, and that if the Executive, without the prior express consent of the Manager of We Sell, takes any
action in violation of Section 7 and/or Section 8, the Company shall be entitled to institute and prosecute proceedings in any
court of competent jurisdiction referred to in Section 9(b) below, to enjoin the Executive from breaching the provisions of Section
7 and/or Section 8. In such action, the Company shall not be required to plead or prove irreparable harm or lack of an adequate
remedy at law or post a bond or any security.         

 

(b)          Any
action must only be commenced in the state or federal courts located in New York County, New York. The Executive and the Company
irrevocably and unconditionally submit to the exclusive jurisdiction of such courts and agree to take any and all future action
necessary to submit to the jurisdiction of such courts. The Executive and the Company irrevocably waive any objection that they
now have or hereafter may have to the laying of venue of any suit, action or proceeding brought in any such court and further irrevocably
waive any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. Final
judgment against the Executive or the Company in any such suit shall be conclusive and may be enforced in other jurisdictions by
suit on the judgment, a certified or true copy of which shall be conclusive evidence of the fact and the amount of any liability
of the Executive or the Company therein described, or by appropriate proceedings under any applicable treaty or otherwise.

 

10.          Conflicts
of Interest. While employed by the Company, the Executive shall not, unless approved by the Manager of We Sell, directly or
indirectly:

 

(a)          participate
as an individual in any way in the benefits of transactions with any of the Company’s suppliers, vendors, or customers, including,
without limitation, having a financial interest in the Company’s suppliers, vendors, or customers, or making loans to, or
receiving loans, from, the Company’s suppliers, vendors, or customers;

 

(b)          realize
a personal gain or advantage from a transaction in which the Company has an interest or use information obtained in connection
with the Executive’s employment with the Company for the Executive’s personal advantage or gain; or

 

(c)          accept
any offer to serve as an officer, director, partner, consultant, manager with, or to be employed in a professional, medical, technical,
or managerial capacity by, a person or entity which does business with the Company.

 

    	 	10	 

     

    

 

11.          Inventions,
Ideas, Processes, and Designs. All inventions, ideas, processes, programs, software, and designs (including all improvements)
(i) conceived or made by the Executive during the course of his employment with the Company (whether or not actually conceived
during regular business hours) and (ii) related to the business of the Company, shall be disclosed in writing promptly to the Manager
of We Sell and shall be the sole and exclusive property of the Company. An invention, idea, process, program, software, or design
(including an improvement to any invention, idea, process, program, software, or design) shall be deemed related to the business
of the Company if (a) it was made with the Company’s funds, personnel, equipment, supplies, facilities, or Confidential Information,
(b) results from work performed by the Executive for the Company, or (c) pertains to the current business or demonstrably anticipated
research or development work of the Company. The Executive shall cooperate with the Company and its attorneys in the preparation
of patent and copyright applications for such developments and, upon request, shall promptly assign all such inventions, ideas,
processes, and designs to the Company. The decision to file for patent or copyright protection or to maintain such development
as a trade secret, or otherwise, shall be in the sole discretion of the Company, and the Executive shall be bound by such decision.

 

12.          Assignability.
The rights and obligations of the Company under this Agreement shall inure to the benefit of and be binding upon the successors
and assigns of the Company, provided that such successor or assign shall acquire all or substantially all of the securities or
assets and business of the Company. The Executive’s obligations hereunder may not be assigned or alienated and any attempt
to do so by the Executive will be void.

 

13.          Severability.

 

(a)          The
Executive expressly agrees that the character, duration and geographical scope of the non-competition provisions set forth in this
Agreement are reasonable in light of the circumstances as they exist on the date hereof. Should a decision, however, be made at
a later date by a court of competent jurisdiction that the character, duration or geographical scope of such provisions is unreasonable,
then it is the intention and the agreement of the Executive and the Company that this Agreement shall be construed by the court
in such a manner as to impose only those restrictions on the Executive’s conduct that are reasonable in the light of the
circumstances and as are necessary to assure to the Company the benefits of this Agreement. If, in any judicial proceeding, a court
shall refuse to enforce all of the separate covenants deemed included herein because taken together they are more extensive than
necessary to assure to the Company the intended benefits of this Agreement, it is expressly understood and agreed by the parties
hereto that the provisions of this Agreement that, if eliminated, would permit the remaining separate provisions to be enforced
in such proceeding shall be deemed eliminated, for the purposes of such proceeding, from this Agreement.

 

(b)          If
any provision of this Agreement otherwise is deemed to be invalid or unenforceable or is prohibited by the laws of the state or
jurisdiction where it is to be performed, this Agreement shall be considered divisible as to such provision and such provision
shall be inoperative in such state or jurisdiction and shall not be part of the consideration moving from either of the parties
to the other. The remaining provisions of this Agreement shall be valid and binding and of like effect as though such provisions
were not included.

 

    	 	11	 

     

    

 

14.        Notices
and Addresses. All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing,
and shall be sufficiently given if delivered to the addressees in person, by FedEx or similar receipted delivery (for next business
day delivery) or by e-mail delivery (in which event a copy shall immediately be sent by FedEx or similar receipted delivery (for
next business day delivery)), as follows:

 

	 	To the Company:	We Sell Cellular, LLC	 
	 	 	171 Madison Avenue, 17th Floor	 
	 	 	New York, New York 10016	 
	 	 	Email: nik@usell.com	 
	 	 	Attention:  Nik Raman, Manager	 
	 	 	 	 
	 	With a Copy to:	Nason, Yeager, Gerson, White & Lioce, P.A.	 
	 	 	1645 Palm Beach Lakes Blvd., Suite 1200	 
	 	 	West Palm Beach, FL 33401 	 
	 	 	Email: mharris@nasonyeager.com	 
	 	 	Attention:  Michael D. Harris, Esq.	 
	 	 	 	 
	 	To the Executive:	Scott Tepfer	 
	 	 	20 Nancy Street, Unit B	 
	 	 	West Babylon, NY 11704	 
	 	 	Email: stepfer@wesellcell.com	 
	 	 	 	 
	 	With a Copy to:	Law Offices of M.W. McCarthy	 
	 	 	362 Pacific Street, Suite 2	 
	 	 	Brooklyn, NY 11217 	 
	 	 	Email: maureen@mwmccarthylaw.com	 
	 	 	Attention:  Maureen W. McCarthy, Esq.	 

 

or to such other address, as either of
them, by notice to the other may designate from time to time.         

 

15.         Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together
shall constitute one and the same instrument. The execution of this Agreement may be by actual or pdf signature.

 

16.          Attorneys’
Fees. In the event that there is any controversy or claim arising out of or relating to this Agreement, or to the interpretation,
breach or enforcement thereof, and any action or proceeding is commenced to enforce the provisions of this Agreement, the prevailing
party shall be entitled to reasonable attorneys’ fees, costs and expenses (including such fees and costs on appeal).

 

17.          Governing
Law. This Agreement and any dispute, disagreement, or issue of construction or interpretation arising hereunder whether relating
to its execution, its validity, the obligations provided therein or performance shall be governed or interpreted according to the
internal laws of the State of New York without regard to choice of law considerations.

 

    	 	12	 

     

    

 

18.          Entire
Agreement. This Agreement constitutes the entire Agreement between the parties and supersedes all prior oral and written agreements
between the parties hereto with respect to the subject matter hereof. Neither this Agreement nor any provision hereof may be changed,
waived, discharged or terminated orally, except by a statement in writing signed by the party or parties against which enforcement
or the change, waiver discharge or termination is sought.

 

19.          Additional
Documents. The parties hereto shall execute such additional instruments as may be reasonably required by their counsel in order
to carry out the purpose and intent of this Agreement and to fulfill the obligations of the parties hereunder.

 

20.          Section
and Paragraph Headings. The section and paragraph headings in this Agreement are for reference purposes only and shall not
affect the meaning or interpretation of this Agreement.

 

21.          Sarbanes-Oxley
Act of 2002.

 

(a)          In
the event the Executive or the Company is the subject of an investigation (whether criminal, civil, or administrative) involving
possible violations of the United States federal securities laws by the Executive, the Manager of We Sell may, in his reasonable
discretion based on the advice of counsel, direct the Company to withhold any and all Bonus or other incentive-based compensation
payments to the Executive which would have otherwise been made pursuant to this Agreement or otherwise would have been paid or
payable by the Company, which the Manager of We Sell believes, in his reasonable discretion based on the advice of counsel, may
or could be considered to be clawed back under Rules passed by the SEC. The withholding of any such payment shall be until such
time as the investigation is concluded without charges having been brought or until the successful conclusion of any legal proceedings
brought in connection with such amounts. Except in the event of an admission of wrongdoing by the Executive or the final adjudication
by a court or the SEC finding the Executive liable for or guilty of violating any of the federal securities laws or Rules, the
Manager shall cause the Company to pay to the Executive such payments with interest thereon
from the date accrued until the date of payment at the rate of 10% per annum. Notwithstanding the exclusion caused by the first
clause of the prior sentence, the Executive shall receive such payments if provided for by a court or by the SEC. 

 

(b)          In
the event that the Company restates any financial statements which have been contained in reports or registration statements filed
with the SEC, and the restatement of the prior financial statements is as the result of material noncompliance with any financial
reporting requirement under the securities laws, the Executive hereby acknowledges that the Company shall recover from the Executive
(i) incentive based compensation (including stock options) awarded during the three year period preceding the date on which the
Company is required to prepare the restatement (ii) in excess of what would have been paid the Executive based on the restated
results. Any rules passed by the SEC under Section 10D of the Securities Exchange Act of 1934 (added by Section 954 of the Dodd-Frank
Wall Street Reform and Consumer Protection Act) shall be incorporated in this Agreement to the extent applicable. The Executive
agrees to reimburse the Company for any incentive compensation received in excess of what would have been paid the Executive based
on the restated results and/or profits realized from the sale of the Company’s securities (including the cash received from
exercise of any options or other awards of stock rights) during the 12-month period following the first public issuance or filing
with the SEC of the report or registration statement (whichever comes first) containing the financial information required to be
restated. Notwithstanding anything to the contrary contained in this Section 21, this Section 21 shall not impose any liability
on the Executive beyond any liability that is imposed under any Rules of the SEC or statutes providing the basis for such Rules.

 

    	 	13	 

     

    

 

(c) Notwithstanding
the last sentence of Section 21(b), if the Company’s common stock is listed on a national securities exchange and such exchange
adopts rules requiring clawbacks beyond what Section 304 of the Sarbanes Oxley Act of 2002 requires, such rules shall be incorporated
in this Agreement to the extent applicable and the Executive shall comply with such rules, including but not limited to executing
any amendment to this Agreement required to incorporate such rules.

 

22.          Section
409A.

 

(a)          Notwithstanding
anything to the contrary contained in this Agreement, if at the time of the Executive’s separation from service within the
meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), the Company determines
that the Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then
to the extent any payment or benefit that the Executive becomes entitled to under this Agreement on account of the Executive’s
separation from service would be considered deferred compensation subject to the 20% additional tax imposed pursuant to Section 409A(a)
of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and
such benefit shall not be provided until the date that is the earlier of (i) six months and one day after the Executive’s
separation from service, or (ii) the Executive’s death (the “Six Month Delay Rule”).

 

(b)          For
purposes of this Section 22, amounts payable under the Agreement should not be considered a deferral of compensation subject to
Section 409A to the extent provided in Treasury Regulation Section 1.409A-1(b)(4) (i.e., short-term deferrals), Treasury Regulation
Section 1.409A-1(b)(9) (i.e., separation pay plans, including the exception under subparagraph (iii)), and other applicable provisions
of Treasury Regulations Sections 1.409A-1 through A-6.

 

(c)          To
the extent that the Six Month Delay Rule applies to payments otherwise payable on an installment basis, the first payment shall
include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application
of the Six Month Delay Rule, and the balance of the installments shall be payable in accordance with their original schedule.

 

(d)          To
the extent that the Six Month Delay Rule applies to the provision of benefits (including, but not limited to, life insurance and
medical insurance), such benefit coverage shall nonetheless be provided to the Executive during the first six months following
his separation from service (the “Six Month Period”), provided that, during such Six-Month Period, the Executive pays
to the Company, on a monthly basis in advance, an amount equal to the Monthly Cost (as defined below) of such benefit coverage.
The Company shall reimburse the Executive for any such payments made by the Executive in a lump sum not later than 30 days
following the sixth month anniversary of the Executive’s separation from service. For purposes of this subparagraph, “Monthly
Cost” means the minimum dollar amount which, if paid by the Executive on a monthly basis in advance, results in the Executive
not being required to recognize any federal income tax on receipt of the benefit coverage during the Six Month Period.

 

    	 	14	 

     

    

 

(e)          The
parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any
provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in
such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may
be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code
and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost
to either party.

 

(f)          The
Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions
of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy
an exemption from, or the conditions of, such Section.

 

Signature Page To Follow

 

    	 	15	 

     

    

 

 

IN WITNESS WHEREOF,
the Company and the Executive have executed this Agreement as of the date and year first above written.

 

	 	BST Distribution, Inc. 
	 	 	 
	 	By:	/s/ Nikhil Raman
	 	 	Nikhil Raman, Chairman
	 	 	 
	 	We Sell Cellular LLC
	 	 	 
	 	By:	/s/ Nikhil Raman
	 	 	Nikhil Raman, Manager

 

	 	Executive:
	 	 
	 	/s/ Scott Tepfer
	 	Scott Tepfer

 

    	 	16	 

     

    

 

 Schedule 4(a)(1)(A)

Initial Base Period

 

See attached Spreadsheet

 

    	 	1	 

     

    

 

 

    	 	2	 

     

    

 

 

 

Schedule 4(a)(1)(B)

Initial Bonus Period

 

See attached Spreadsheet

 

    	 	3	 

     

    

 

 

    	 	4	 

     

    

 

Schedule 4(a)(2)

Possible Base Salary Reduction

 

In calculating the base salary of the Executive for a six-month
Measuring Period, the following formula shall be used, unless the result is greater than or equal to $250,000, in which case the
base salary for such six-month Measuring Period will be $250,000:

 

	$250,000 plus ($70,000 times (X divided by Y))

 

Where

X is the Actual EBITDA minus Threshold EBITDA

Y is the Threshold EBITDA

 

Or, expressed numerically:

 

$250,000 + ($70,000 x ((Actual EBITDA – Threshold EBITDA)
/ Threshold EBITDA))

 

By way of example, if the EBITDA Threshold
for the previous Measuring Period is $1,000,000, and the actual EBITDA for the previous Measuring Period is $500,000, then the
base salary is reduced as follows:

 

$250,000 + ($70,000 x (($500,000 - $1,000,000)
/ $1,000,000)), or

$250,000 + ($70,000 x (-0.5)), or $250,000
- $35,000, or $215,000

 

By way of a second example, if the EBITDA
Threshold is $1,000,000, the actual EBITDA for the Measuring Period is $2,000,000, then the calculation results in:

 

$250,000 + ($70,000 x (($2,000,000 - $1,000,000)
/ $1,000,000)), or

$250,000 + ($70,000 x (1.0)), or $250,000
+ $70,000, or $320,000

 

Because $320,000 is greater than $250,000,
the base salary for the six-month Measuring Period remains at $250,000

 

The calculation of base salary for a Measuring
Period will always be based on the EBITDA calculations for the previous (most recently ended) Measuring Period.

 

The Executive’s base salary for a six-month
Measuring Period will never be reduced below $180,000 ($360,000 per annum or $30,000 per month).

 

    	 	1	 

     

    

 

Schedule 4(a)(3)

Adjustments to Base Salary

 

If actual EBITDA for a six-month Measuring Period is less than
Threshold EBITDA for that Measuring Period, an adjustment will be made to the Base Salary for the Executive effective for the next
Measuring Period. Base Salary for the next six-month Measuring Period will be the lesser of $250,000 or

 

$250,000 plus ($70,000 times (X divided by Y))

 

Where

X is the Actual EBITDA minus Threshold EBITDA

Y is the Threshold EBITDA

 

Or, expressed numerically:

 

$250,000 + ($70,000 x ((Actual EBITDA – Threshold EBITDA)
/ Threshold EBITDA))

 

For purposes of this Schedule, “Base Salary Paid”
means the Base Salary actually paid to the Executive during any six-month Measuring Period and “Base Salary Earned”
means the Adjusted Base Salary as calculated under Section 4(a) at the end of such Measuring Period.

“Carryover Deficit” will equal Base Salary Paid
minus Base Salary Earned.

 

By way of example, if Base Salary Paid is $250,000, Actual EBITDA
is $1,000,000 and Threshold EBITDA is $1,290,000, then:

 

Base Salary Paid will be $250,000

Base Salary Earned will be $250,000 + ($70,000 x (($1,000,000
- $1,290,000) / $1,290,000)), or $234,264

Carryover Deficit will be $250,000 - $234,264, or $15,736

 

In calculating the Adjusted Base Salary for the Executive for
any Measuring Period starting on or after June 30, 2016, Base Salary Paid for such Measuring Period will be Base Salary Earned
from the previous Measuring Period. Base Salary Earned will be the lesser of $250,000 or

 

$250,000 plus ($70,000 times (X divided by Y))

 

Where

X is the Actual EBITDA minus Threshold EBITDA

Y is the Threshold EBITDA

Carryover Deficit will equal the Carryover Deficit from the
prior Measuring Period minus the Earned Credit. “Earned Credit” will be Base Salary Earned minus Base Salary Paid,
unless the result is less than $0, in which case the Earned Credit will be $0.

 

    	 	2	 

     

    

 

By way of example, if Base Salary Earned from the prior Measuring
Period is $234,264, Actual EBITDA is $1,500,000, Threshold EBITDA is $1,843,000, and Carryover Deficit from the prior Measuring
Period is $15,736, then:

 

Base Salary Paid will be $234,264

Base Salary Earned will be $250,000 + ($70,000 x (($1,500,000
- $1,843,000) / $1,843,000)), or $236,972

Earned Credit will be $236,972 - $234,264, or $2,709

Carryover Deficit will be $15,736 - $2,709, or $13,028

 

    	 	3	 

     

    

 

Schedule 4(b)(1)

Bonus Calculation 

 

If actual EBITDA for a Measuring Period is more than the Threshold
EBITDA but less than 150% of Threshold EBITDA for that Measuring Period, the following formula shall be used in calculating the
bonus to be paid to the Executive for the Measuring Period:

 

	X times (Y divided by Z)

 

Where:

X is 25% times 250,000, or 62,500

Y is Actual EBITDA minus Threshold EBITDA, and

Z is (1.5 times Threshold EBITDA) minus Threshold EBITDA

 

Or, expressed numerically:

 

(0.25 x 250,000) x ((Actual EBITDA minus Threshold EBITDA) /
((1.5 x Threshold EBITDA) – Threshold EBITDA))

 

By way of example, if an EBITDA Threshold is $1,000,000 and the actual EBITDA for the Measuring Period is $1,250,000, then the
Bonus is

 

(25% x $250,000) x ($1,250,000-$1,000,000)/((1.5
x $1,000,000) - $1,000,000), or

$62,500 x ($250,000/$500,000), or $31,250

 

    	 	4	 

     

    

 

Schedule 4(b)(2)

Additional Bonus Calculations

 

Assuming that actual EBITDA for a Measuring Period exceeds 150%
of Threshold EBITDA for that Measuring Period, the following formula shall be used in calculating the bonus to be paid to the Executive
for the Measuring Period:

 

X plus (Y divided by Z)

 

Where:

X is 25% times 250,000, or 62,500

Y is (75% times 250,000) times (Actual EBITDA minus (1.5 times
Threshold EBITDA))

Z is EBITDA Target minus (1.5 times Threshold EBITDA)

 

Or, expressed numerically:

 

(0.25 x 250,000) + ((0.75 x 250,000) x (Actual EBITDA –
(1.5 x Threshold EBITDA)) / (EBITDA Target – (1.5 x Threshold EBITDA))

By way of example, if an EBITDA Threshold
is $1,000,000, the EBITDA Target is $2,000,000, and the actual EBITDA for the Measuring Period is $1,750,000, then the Bonus is

 

(25% x $250,000) + ((75% x $250,000) x ($1,750,000
- (1.5 x $1,000,000)) /

($2,000,000 – (1.5 x $1,000,000)), or

$62,500 + (($187,500 x $250,000)/$500,000),
or

$62,500 + $93,750, or $156,250

 

    	 	5Exhibit 10.7

 

NOTE PURCHASE AGREEMENT

 

BAM ADMINISTRATIVE SERVICES, LLC,

as Agent

 

PURCHASERS

From Time to Time Party Hereto,

 

USELL.COM, INC.,

BST DISTRIBUTION, INC.

 

and

 

WE SELL CELLULAR LLC

 

Dated: October 23, 2015

 

     

     

    

 

Table
of Contents 

 

	 	 	 	Page
	 	 	 	 
	1.	Agreement to Sell and Purchase	1
	 	1.1	Initial Offering	1
	 	1.2	Deferred Draw Notes	2
	 	1.3	Purchase Price	3
	 	 	 	 
	2.	Disbursement Letters;  Closing Expenses	3
	 	 	 	 
	3.	Closing Shares	3
	 	 	 	 
	4.	Closing, Delivery and Payment	3
	 	4.1	Closing	3
	 	4.2	Delivery	4
	 	 	 	 
	5.	Cash Management; Application of Proceeds.	4
	 	5.1	Cash Management	4
	 	5.2	Application of Proceeds	5
	 	5.3	Disbursements from Agent Controlled Account	5
	 	 	 	 
	6.	Representations and Warranties of any Company	5
	 	6.1	Organization, Good Standing and Qualification	5
	 	6.2	Subsidiaries	6
	 	6.3	Capitalization; Voting Rights	6
	 	6.4	Authorization; Binding Obligations	7
	 	6.5	Liabilities; Solvency	7
	 	6.6	Agreements; Action	8
	 	6.7	Internal Accounting Controls; Disclosure Controls and Procedures	9
	 	6.8	SEC Documents; Financial Statements; Sarbanes-Oxley	10
	 	6.9	Obligations to Related Parties	12
	 	6.10	Changes	13
	 	6.11	Title to Properties and Assets; Liens, Etc	14
	 	6.12	Intellectual Property	15
	 	6.13	Compliance with Other Instruments	16
	 	6.14	Litigation	17
	 	6.15	Tax Returns and Payments	17
	 	6.16	Employees	17
	 	6.17	Registration Rights and Voting Rights	18
	 	6.18	Compliance with Laws; Permits	18
	 	6.19	Environmental and Safety Laws	19
	 	6.20	Valid Offering	19
	 	6.21	Acknowledgment Regarding Purchaser’s Purchase of Notes	19
	 	6.22	No Material Adverse Effect; No Undisclosed Liabilities	19
	 	6.23	General Solicitation	20
	 	6.24	No Integrated Offering	20
	 	6.25	Listing	20
	 	6.26	Investment Company	20
	 	6.27	No Disqualification Events	20

 

    i 

     

    

  

Table
of Contents 

 

	 	 	 	Page
	 	 	 	 
	 	6.28	Full Disclosure	21
	 	6.29	Insurance	21
	 	6.30	Dilution	21
	 	6.31	Patriot Act	21
	 	6.32	ERISA	22
	 	6.33	Status of Certain Subsidiaries	22
	 	 	 	 
	7.	Representations and Warranties of each Purchaser	22
	 	7.1	Organization, Good Standing and Qualification	22
	 	7.2	Intentionally Omitted	22
	 	7.3	Requisite Power and Authority	23
	 	7.4	Investment Representations	23
	 	7.5	Transfer or Resale	23
	 	7.6	Purchaser Bears Economic Risk	24
	 	7.7	Acquisition for Own Account	24
	 	7.8	Purchaser Can Protect Its Interest	24
	 	7.9	Accredited Investor	24
	 	7.10	Legends	24
	 	 	 	 
	8.	Covenants of Companies	25
	 	8.1	Stop-Orders	25
	 	8.2	Listing	25
	 	8.3	Market Regulations	25
	 	8.4	Reporting Requirements	25
	 	8.5	Form D and Blue Sky	27
	 	8.6	Reporting Status	27
	 	8.7	Internal Accounting Controls	28
	 	8.8	Listing	28
	 	8.9	Disclosure of Transactions	28
	 	8.10	Disqualification Events	29
	 	8.11	No Integrated Offering	29
	 	8.12	Use of Funds	29
	 	8.13	Access to Facilities	29
	 	8.14	Taxes	30
	 	8.15	Insurance	31
	 	8.16	Intellectual Property	32
	 	8.17	Properties	33
	 	8.18	Confidentiality	33
	 	8.19	Environmental Matters	33
	 	8.20	Compliance with Laws	33
	 	8.21	Licenses and Permits	33
	 	8.22	Further Assurances	33
	 	8.23	Financial Covenants	34
	 	8.24	Required Approvals	35
	 	8.25	Reissuance of Equity Interests	37
	 	8.26	Margin Stock	38
	 	8.27	FIRPTA	38

 

    ii 

     

    

 

Table
of Contents 

 

	 	 	 	Page
	 	 	 	 
	 	8.28	Financing Right of First Refusal	38
	 	8.29	Intentionally Omitted	39
	 	8.30	No Restriction of Additional Financings	39
	 	8.31	Changes to Fiscal Year	39
	 	8.32	Reimbursement of Monitoring Expenses	39
	 	8.33	Limitation on Amendments to Material Agreements	39
	 	8.34	Regulatory Matters	39
	 	8.35	Deposit Accounts	40
	 	8.36	Post-Closing Covenant	40
	 	 	 	 
	9.	Covenants of Purchasers	40
	 	9.1	Confidentiality	40
	 	9.2	Non-Public Information	40
	 	9.3	Limitation on Acquisition of Common Stock of USELL	41
	 	 	 	 
	10.	Covenants of Companies and Purchasers Regarding Indemnification	41
	 	 	 	 
	11.	Registration Rights	42
	 	11.1	Registration Rights	42
	 	11.2	Offering Restrictions	42
	 	 	 	 
	12.	Conditions Precedent	42
	 	12.1	Initial Notes	42
	 	12.2	Delayed Draw Notes	45
	 	 	 	 
	13.	Miscellaneous	46
	 	13.1	Governing Law, Jurisdiction and Waiver of Jury Trial	46
	 	13.2	Severability	47
	 	13.3	Independent Nature of Purchasers	48
	 	13.4	Survival, Etc	48
	 	13.5	Successors	48
	 	13.6	Entire Agreement; Maximum Interest	49
	 	13.7	Amendment and Waiver	49
	 	13.8	Delays or Omissions; Remedies	50
	 	13.9	Notices	50
	 	13.10	Form of Payment	50
	 	13.11	Attorneys’ Fees	50
	 	13.12	Titles and Subtitles	51
	 	13.13	Signatures; Counterparts	51
	 	13.14	Broker’s Fees	51
	 	13.15	Construction	51
	 	13.16	Joint and Several Obligations	51
	 	13.17	Agency	52
	 	13.18	Costs and Expenses	52

 

    iii 

     

    

 

LIST OF EXHIBITS

 

	Form of Term Notes	Exhibit A
	Form of Security Agreement	Exhibit B
	Form of Pledge Agreement	Exhibit C
	Form of Subsidiary Guaranty	Exhibit D
	Form of Account Control Agreement	Exhibit E

 

LIST OF SCHEDULES

 

	Schedule 1	Purchaser Commitments
	Schedule 2	Closing Shareholders and Closing Shares
	Schedule 6.2	Subsidiaries
	Schedule 6.3	Capitalization
	Schedule 6.5	Liabilities
	Schedule 6.6	Agreements & Actions
	Schedule 6.8	Reporting Documents
	Schedule 6.9	Obligations to Related Parties
	Schedule 6.10	Changes
	Schedule 6.11	Permitted Encumbrances
	Schedule 6.12	Intellectual Property
	Schedule 6.14	Litigation
	Schedule 6.15	Taxes
	Schedule 6.16	Employee Agreement and Issues
	Schedule 6.17	Registration Rights
	Schedule 6.18	Compliance with Laws
	Schedule 6.22	No Material Adverse Effect
	Schedule 8.12	Use of Funds
	Schedule 9.14	Properties
	Schedule 8.24	Existing Indebtedness
	Schedule 8.33	Material Agreements
	Schedule 8.35	Deposit Accounts
	Schedule 8.36	Post-Closing Covenant
	Schedule 12.1	Indebtedness to be Paid Off

 

    iv 

     

    

 

NOTE PURCHASE AGREEMENT

 

THIS NOTE PURCHASE
AGREEMENT (this “Agreement”) is made and entered into as of October 23, 2015, by and among USELL.COM, INC.,
a Delaware corporation (“USELL”), BST DISTRIBUTION, INC., a New York corporation (“BST”),
WE SELL CELLULAR LLC, a Delaware limited liability company (“WE SELL” together with USELL and BST, each a “Company”
and collectively the “Companies”), Purchasers from time to time a party hereto (each a “Purchaser”
and collectively, the “Purchasers”), BAM ADMINISTRATIVE SERVICES, LLC., a Delaware limited liability company,
as agent for each Purchaser, (the “Agent” and together with Purchasers, the “Creditor Parties”).

 

RECITALS

 

WHEREAS, Companies
have authorized the sale to each Purchaser of original issue discount Secured Term Notes;

 

WHEREAS, USELL wishes
to issue to each Purchaser shares of USELL’s common stock, $0.01 par value per share (the “Common Stock”)
in connection with such Purchaser’s purchase of the applicable Notes;

 

WHEREAS, each Purchaser
desires to purchase the applicable Notes and receive such Common Stock on the terms and conditions set forth herein; and

 

WHEREAS, each Company
desires to issue and sell the applicable Notes and, in the case of USELL, issue Common Stock, to each Purchaser on the terms and
conditions set forth herein.

 

AGREEMENT

 

NOW, THEREFORE, in
consideration of the foregoing recitals and the mutual promises, representations, warranties and covenants hereinafter set forth
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:

 

1.    
      Agreement to Sell and Purchase.

 

1.1           Initial
Offering. Pursuant to the terms and conditions set forth in this Agreement, on
the Initial Closing Date (as defined in Section 4.1), Companies shall sell to each Purchaser, and each Purchaser shall purchase
from Companies, the applicable original issue discount Notes listed on Schedule 1 under the heading “Initial Notes”
and set forth opposite such Purchaser’s name, in the original aggregate principal amount of Four Million Forty Thousand
dollars ($4,040,000) (each as amended, restated, modified and/or supplemented from time to time, an “Initial Note”
and collectively the “Initial Notes”; and the result of (i) the principal amount of the Initial Notes purchased
by a Purchaser and listed on Schedule 1 under the heading “Initial Notes” set forth opposite such Purchaser’s
name, divided by (ii) Four Million Forty Thousand dollars ($4,040,000) being referred to as such Purchaser’s “Allocation
Percentage”). The sale of the Initial Notes and the Closing Shares (as such term is defined below) on the Initial Closing
Date shall be known as the “Initial Offering.” The Initial Notes will mature on the Maturity Date (as defined
in each Initial Note). The Initial Notes shall be substantially in the form attached hereto as Exhibit A and shall include
such notations, legends or endorsements set forth therefor or required by law. The proceeds of the Initial Notes are to be used
in accordance with Section 8.12 of this Agreement.

 

     

     

    

 

1.2           Deferred
Draw Notes. Pursuant to the terms and conditions set forth in this Agreement, Companies
have the right (which right may be exercised two (2) times only) to request each Purchaser to purchase from Companies on such
date (the “Deferred Draw Closing Date”) as is mutually agreed to by Companies and Purchasers but in any event
on or prior to the date that is six (6) months from the Initial Closing Date, additional original issue discount Notes in the
principal amount equal to the product of (a) the Deferred Draw Note Aggregate Principal Amount (as defined below), and (b) such
Purchaser’s Allocation Percentage (each as amended, restated, modified and/or supplemented from time to time, a “Deferred
Draw Note” and collectively the “Deferred Draw Notes”; and together with the Initial Notes, each
individually a “Note” and collectively the “Notes”); provided that (i) the proceeds of the
Deferred Draw Notes are used in accordance with Section 8.12 of this Agreement and legal fees and other closing expenses related
to the closing of the Deferred Draw Notes, (ii) the aggregate principal amount of the Deferred Draw Notes does not exceed Four
Million Forty Thousand dollars ($4,040,000), but is greater than or equal to Two Million Twenty Thousand dollars ($2,020,000),
allocated pro rata among Purchasers in accordance with each Purchaser’s Allocation Percentage, (iii) any Company shall have
provided written notice (the “Deferred Draw Notice”) to Purchasers at least 10 days prior to the Deferred Draw
Closing Date, which notice shall state the proposed date of such borrowing, the aggregate amount of Deferred Draw Notes being
requested (the “Deferred Draw Note Aggregate Principal Amount”), (iv) after giving effect to such Deferred
Draw Note, Companies shall be in compliance with Section 8.23(b) and after giving effect to the purchase of such Deferred Draw
Note, (v) both before and after the consummation of the purchase of the Deferred Draw Notes and the use of proceeds thereof, no
Default or Event of Default (as defined in each Note) shall have occurred and be continuing, (vi) all assets purchased with
the proceeds from the Deferred Draw Notes will be subject to a perfected first priority lien in favor of Agent for the benefit
of Purchasers, (vii) Companies and Guarantors (as defined in the Subsidiary Guaranty) are, and immediately following such Deferred
Draw Closing Date would be, in compliance with the terms of this Agreement and the Related Agreements (as defined below), (viii)
the other conditions to Purchasers’ obligations to purchase the Initial Notes are satisfied as if applied to the Deferred
Draw Notes, and (ix) prior to the Deferred Draw Closing Date, Companies receive written confirmation from Agent of its election,
on behalf of Purchasers, to purchase the proposed Deferred Draw Notes, which election will be in the sole discretion of Agent.
The Deferred Draw Notes shall be substantially in the form attached hereto as Exhibit A and shall include such notations,
legends or endorsements set forth therefor or required by law. The Deferred Draw Notes will have the same Maturity Date and repayment
schedule as the Initial Notes. Each Deferred Draw Note shall be dated the date of its issuance. The terms and provisions contained
in the Deferred Draw Notes when issued shall constitute, and are hereby expressly made, a part of this Agreement, and to the extent
applicable, any Company and Purchasers, by their execution and delivery of this Agreement, expressly agree to such terms and provisions
and to be bound thereby. For purposes of this Agreement, “Default” means any of the events specified in Section
1.6 of the Notes which constitutes an Event of Default or which, upon the giving of notice or the lapse of time, or both, pursuant
to Section 1.6 of the Notes would, unless cured or waived, become an Event of Default.

 

    	 	2	 

     

    

  

1.3           Purchase
Price. The aggregate purchase price (the “Purchase Price”) for
the Notes and the Closing Shares purchased by Purchasers shall equal Four Million dollars ($4,000,000) for the Initial Notes and
the Initial Closing Shares and Four Million dollars ($4,000,000) for the Deferred Draw Notes and the Additional Closing Shares.

 

2.     
     Disbursement Letters; Closing Expenses. Prior to each Closing Date (as defined
below), Companies shall issue to each Purchaser a disbursement letter (collectively the “Disbursement
Letters” and each, a “Disbursement Letter”) setting forth the Purchase Price payable by such
Purchaser at such Closing Date and the recipients to receive such proceeds on behalf of Companies and to the extent that any
proceeds are to be payable to any of the Companies such amounts shall be deposited in the Agent Controlled Account (as such
term is defined in Section 5.1 below). All expenses incurred by Agent and Purchasers in connection with the review,
documentation and closing of transactions contemplated herein and in the Related Agreements (net of deposits previously paid
by Companies) shall be paid by Companies on the applicable Closing Date, as shall be set forth in the Disbursement Letters.
The Disbursement Letters shall be subject to Agent’s review and approval.

 

3.  
        Closing Shares.

 

(a)          On
the Initial Closing Date, USELL will issue and deliver to each Purchaser the number of shares of Common Stock set forth opposite
its name on Schedule 2 (the “Initial Closing Shares”) in connection with the Initial Offering pursuant
to Section 1 hereof.

 

(b)          On
each Delayed Draw Closing Date, USELL will issue and deliver to each Purchaser, such Purchaser’s Allocation of an amount
equal to 60,000 shares of Common Stock for each $1,000,000 of Delayed Draw Notes being purchased (the “Additional Closing
Shares” together with the Initial Closing Shares, the “Closing Shares”).

 

(c)          All
the representations, covenants, warranties, undertakings, and indemnification, and other rights made or granted to or for the benefit
of each Purchaser Party by Companies, to the extent relevant to the Closing Shares, are hereby also made and granted for the benefit
of the holder of the Closing Shares.

 

4.   
       Closing, Delivery and Payment.

 

4.1           Closing.
Subject to the terms and conditions herein, the closing of the Initial Offering shall take place on the Initial Closing Date,
and the closing of the issuance of the Deferred Draw Notes shall take place on the Deferred Draw Closing Date, in each case, at
such time or place as any Company and Agent may mutually agree (such dates are hereinafter referred to as the “Initial
Closing Date” and “Deferred Draw Closing Date,” as applicable, and each a “Closing Date”).

 

    	 	3	 

     

    

  

4.2           Delivery.
At the closing of the Initial Offering on the Initial Closing Date and the closing of the issuance of the Deferred Draw Notes
on the Deferred Draw Closing Date, as applicable, Companies will deliver to each Purchaser, among other things, the applicable
Initial Note or Deferred Draw Note purchased by such Purchaser, USELL will deliver to each Purchaser the Closing Shares and such
Purchaser will deliver to any Company the amount set forth opposite its name in the Disbursement Letter for such Purchaser by
wire transfer of immediately available funds to an account designated by any Company in the Disbursement Letters. Each Company
hereby acknowledges and agrees that each Purchaser’s obligation to purchase the applicable Initial Note or Deferred Draw
Note from any Company on the Initial Closing Date or Deferred Draw Closing Date, as applicable, shall be contingent upon the satisfaction
(or waiver by Agent) as determined by Agent in its good faith discretion, of the conditions precedent set forth herein.

  

5.    
      Cash Management; Application of Proceeds.

 

5.1           Cash
Management. Each Company will, at its expense, establish (and revise
from time to time as Lender may require) procedures acceptable to Agent, in Agent’s sole discretion, for the collection
of checks, wire transfers and all other proceeds of all of such Company’s account receivable and other Collateral (“Collections”),
which shall include directing all account debtors, including PayPal and any and all other third party payors, to send all account
proceeds directly to an account designated by Agent in the name of Agent (the “Agent Controlled Account”),
depositing all Collections received by such Company into an Agent Controlled Account and depositing all the proceeds from the
purchase of the Notes not disbursed on the applicable Closing Date. In addition, each Company shall provide Agent at all times
with the information necessary to access and/or obtain funds from any accounts maintained by third party payors on behalf of such
Company. Companies shall maintain cash in the Agent Controlled Account in an amount sufficient to comply with Section 8.23(b).
A Company may request that Agent disburse the amounts in the Agent Controlled Account to a Springing Controlled Account (as defined
below), provided that no Event of Default has occurred and be continuing and after giving effect to such disbursement, Companies
shall be in compliance with Section 8.23(b). Within forty five (45) days of the Initial Closing Date, each Company and each of
its Subsidiaries (as such term is defined in Section 6.1 below) shall have entered into Account Control Agreements (as such term
is defined in Section 6.1 below) with respect to each of its deposit accounts (other than the “Non-Controlled Accounts”
(as such term is defined below)) providing for “springing” cash dominion over disbursement accounts and other deposit
accounts (such accounts, the “Springing Controlled Accounts”). Each Company shall provide Agent with the information
necessary for Agent to have online access to account balances and activity for each bank account maintained by such Company and
no Company shall change any such information unless and until Agent shall have provided such Company written notice acknowledging
Agent’s receipt of such updated information. With respect to the Springing Controlled Accounts, Agent shall not deliver
to the relevant depository a notice or other instruction which provides for exclusive control over such account by Agent unless
an Event of Default shall have occurred and be continuing. Within forty-five (45) days of the Initial Closing Date, the Non-Controlled
Accounts shall be closed. All amounts in Non-Controlled Accounts in excess of $25,000 in the aggregate at any time shall be remitted
by each Company and each Subsidiary to a Springing Controlled Account within two (2) business days of receipt therein. As used
in this Agreement, “Non-Controlled Accounts” means deposit accounts of each Company and its Subsidiaries  not
used as the main depository or disbursement account of such Person (as such term is defined below).

 

    	 	4	 

     

    

  

5.2           Application
of Proceeds. Agent is hereby directed to apply amounts deposited in the Agent Controlled Accounts shall be applied as follows:
first, to payment of costs and expenses of Agent and Purchasers payable or reimbursable by Companies under this Agreement or any
Related Agreement; second, to payment of all accrued unpaid interest on the Notes; third, to payment of principal of the Notes
then due and payable; fourth, to payment of any other amounts owing constituting Liabilities (as such term is defined in Section
13.16 below) the due and payable; and fifth, absent the occurrence and continuation of an Event of Default, in accordance with
Section 5.3 below.

 

5.3           Disbursements
from Agent Controlled Account. Companies shall request that Agent consent to the release of funds from an Agent Controlled
Account by written request to Agent at least two (2) business days prior to the requested release. If an Event of Default has occurred
and is continuing, Agent shall have no obligation to authorize the release of funds from an Agent Controlled Account.

 

6.     
     Representations and Warranties of any Company. Each Company hereby represents and
warrants to each Purchaser as follows:

 

6.1           Organization,
Good Standing and Qualification. Such Company and each of its Subsidiaries is a
corporation, partnership or limited liability company, as the case may be, duly organized, validly existing and in good standing
under the laws of its jurisdiction of organization. Such Company and each of its Subsidiaries has the corporate, limited liability
company or partnership, as the case may be, power and authority to own and operate its properties and assets and, insofar as it
is or shall be a party thereto, to (1) execute and deliver (i) this Agreement, (ii) the Notes to be issued in connection with
this Agreement, (iii) the Closing Shares, (iv) the Security Agreement to be dated as of the Initial Closing Date among Companies,
all of the Subsidiaries of Companies and Agent, in the form attached hereto as Exhibit B with any changes thereto as are
approved by Companies and Agent (as amended, restated, modified and/or supplemented from time to time, the “Security
Agreement”), (v) the Pledge Agreement to be dated as of the Initial Closing Date among Companies, certain Subsidiaries
of Companies and Agent, in the form attached hereto as Exhibit C with any changes thereto as are approved by Companies
and Agent (as amended, restated, modified and/or supplemented from time to time, the “Pledge Agreement”), (vi)
the Guaranty Agreement dated as of the Initial Closing Date among all of the Subsidiaries of Companies (collectively, “Guarantors”)
in favor of Creditor Parties, in the form attached hereto as Exhibit D with any changes thereto as are approved by Companies
and Agent (as amended, restated, modified and/or supplemented from time to time, the “Subsidiary Guaranty”),
(vii) Account Control Agreements, in each case, dated as of the Initial Closing Date, among Companies and the Subsidiaries of
Companies, Agent and the applicable financial institution in the form attached hereto as Exhibit E with any changes thereto
as are approved by Companies and Agent (as amended, restated, modified and/or supplemented from time to time, each, an “Account
Control Agreement” and together, the “Account Control Agreements”), and (viii) all other documents,
instruments, guarantees and agreements entered into in connection with the transactions contemplated hereby and thereby
 (the preceding clauses (ii) through (viii), collectively, the “Related Agreements”); (2) issue
and sell the Notes; (3) issue the Closing Shares and (4) carry out the provisions of this Agreement and the Related Agreements
and to carry on its business as presently conducted. Each Company and each of its Subsidiaries is duly qualified and is authorized
to do business and is in good standing as a foreign corporation, partnership or limited liability company, as the case may be,
in all jurisdictions in which the nature or location of its activities and of its properties (both owned and leased) makes such
qualification necessary, except for those jurisdictions in which failure to do so has not, or could not reasonably be expected
to have, individually or in the aggregate, a material adverse effect on (a) the business, assets, liabilities, condition (financial
or otherwise), properties, operations or prospects of Companies and Subsidiaries of Companies, taken as a whole, (b) the legality,
invalidity, enforceability, perfection or priority of the security interests and liens of Agent upon the Collateral (as defined
in the Security Agreement) or (c) the ability of any Company and its Subsidiaries, taken as a whole, to perform their obligations
under this Agreement or the Related Agreements (a “Material Adverse Effect”). As used herein, the term “Subsidiary”
means, with respect to any Person, any corporation, partnership, joint venture, limited liability company, association or other
entity, the management of which is, directly or indirectly, controlled by, or of which an aggregate of more than fifty percent
(50%) of the voting Stock is, at the time, owned or controlled directly or indirectly by, such Person or one or more Subsidiaries
of such Person. As used herein, the term “Person” means any individual, partnership, corporation (including
a business trust and a public benefit corporation), joint stock company, estate, association, firm, enterprise, trust, limited
liability company, unincorporated association, joint venture and any other entity or Governmental Authority (as defined below).

 

    	 	5	 

     

    

  

6.2         Subsidiaries.
Each Company holds all right, title and interest in and to 100% of the capital stock, equity, membership interests or similar
interests of each of the Subsidiaries as reflected on Schedule 6.2, in each case, free and clear of any Liens (as defined
below), including any restriction on the use, voting, transfer, receipt of income or other exercise of any attributes of free
and clear ownership by a current holder. Except as set forth on Schedule 6.2, no Company nor any of its Subsidiaries directly
or indirectly owns any security, equity or beneficial ownership interest in any other Person (including through joint venture
or partnership agreements) or has any other interest in any other Person.

 

6.3         Capitalization;
Voting Rights.

 

(a)          The
authorized capital stock of USELL, as of the date hereof is set forth on Schedule 6.3.

 

(b)          Except
as disclosed on Schedule 6.3, there are no outstanding options, warrants, rights (including conversion or preemptive rights
and rights of first refusal), proxy or equity holder agreements, or arrangements or agreements of any kind for the purchase or
acquisition from any Company or any Subsidiary of any of its equity interests. Except as disclosed on Schedule 6.3,
neither the offer, issuance or sale of any of the Notes, or the issuance of any of the Closing Shares, nor the consummation of
any transaction contemplated hereby will result in a change in the price or number of any equity interests of any Company outstanding,
under anti-dilution or other similar provisions contained in or affecting any such equity interests.

 

(c)          Except
as disclosed on Schedule 6.3, all issued and outstanding shares of each Company’s common stock: (i) have been duly
authorized and validly issued and are fully paid and non-assessable; and (ii) were issued in compliance with all applicable state
and federal laws concerning the issuance of equity interests.

 

(d)          The
rights, preferences, privileges and restrictions of the shares of each Company’s equities are as stated in such Company’s
certificate or articles of formation. The Closing Shares have been issued in compliance with the provisions of this Agreement and
the applicable Company’s organizational documents and have been validly issued, fully paid and are non-assessable, and all
equity interests will be free of any Liens; provided, however, that the equity interests may be subject to restrictions
on transfer under state and/or federal securities laws as set forth herein or as otherwise required by such laws at the time a
transfer is proposed.

 

    	 	6	 

     

    

  

6.4         Authorization;
Binding Obligations. All corporate, partnership or limited liability company, as
the case may be, action on the part of each Company and each of its Subsidiaries (including their respective officers and directors)
necessary for the authorization of this Agreement and the Related Agreements, the performance of all obligations of each Company
and its Subsidiaries hereunder and under the other Related Agreements at the Initial Closing Date and/or the Deferred Draw Closing
Date, as applicable, and the authorization, sale, issuance and delivery of the Notes and Closing Shares has been taken or will
be taken prior to the applicable closing date. This Agreement and the Related Agreements, when executed and delivered and to the
extent it is a party thereto, will be valid and binding obligations of each Company and each of its Subsidiaries, enforceable
against each such Person in accordance with their terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other laws of general application affecting enforcement of creditors’ rights; and (b) general principles of
equity that restrict the availability of equitable or legal remedies. The sale of the Notes is not and will not be subject to
any preemptive rights or rights of first refusal that have not been properly waived or complied with. The issuance of the Closing
Shares is not subject to any preemptive rights or rights of first refusal that have not been properly waived or complied with.

 

6.5         Liabilities;
Solvency.

 

(a)          Except
as set forth in the consolidated balance sheet of USELL and its Subsidiaries and WE SELL and BST, each dated September 30, 2015,
or on Schedule 6.5 and for Permitted Encumbrances (as defined below), no Company nor any of its Subsidiaries has any material
liabilities, except current liabilities incurred in the ordinary course of business since September 30, 2015.

 

(b)          Both
before and after giving effect to (a) the transactions contemplated hereby that are to be consummated on each Closing Date, (b)
the disbursement of the proceeds of, or the assumption of the liability in respect of, the Notes pursuant to the instructions or
agreement of Companies and (c) the payment and accrual of all transaction costs in connection with the foregoing, Companies and
Guarantors, on a consolidated basis, are and will be, Solvent. For purposes of this Agreement, “Solvent” means,
with respect to any Person on a particular date, that on such date (a) the fair value of the property of such Person is greater
than the total amount of liabilities, including contingent liabilities, of such Person; (b) the present fair salable value
of the assets of such Person is not less than the amount that will be required to pay the probable liability of such Person on
its debts as they become absolute and matured; (c) such Person does not intend to, and does not believe that it will, incur debts
or liabilities beyond such Person’s ability to pay as such debts and liabilities mature; and (d) such Person is not engaged
in a business or transaction, and is not about to engage in a business or transaction, for which such Person’s property would
constitute an unreasonably small capital. The amount of contingent liabilities (such as litigation, guaranties and pension plan
liabilities) at any time shall be computed as the amount that, in light of all the facts and circumstances existing at the time,
represents the amount that can reasonably be expected to become an actual or matured liability.

 

    	 	7	 

     

    

  

6.6          Agreements;
Action. Except as set forth on Schedule 6.6:

 

(a)          There
are no agreements, understandings, instruments, contracts, judgments, orders, writs or decrees to which any Company or any of its
Subsidiaries is a party or by which it is bound which may involve: (i) obligations (contingent or otherwise) of, or payments to,
any Company or any of its Subsidiaries in excess of $50,000 (other than obligations of, or payments to, any Company or any of its
Subsidiaries arising from purchase or sale agreements, contracts for services, marketing and advertising related agreements, etc.
entered into in the ordinary course of business); or (ii) the transfer or license of any patent, copyright, trade secret or other
proprietary right to or from any Company or any of its Subsidiaries (other than licenses arising from the purchase of “off
the shelf” or other standard products); or (iii) provisions restricting the development, manufacture or distribution of any
Company’s or any of its Subsidiaries’ products or services; or (iv) indemnification by any Company or any of its Subsidiaries
with respect to infringements of proprietary rights.

 

(b)          Since
June 30, 2015 (as to WE SELL and BST) and September 30, 2015 as to USELL (the “Measurement Date”), no Company
nor any of its Subsidiaries has: (i) declared or paid any dividends, or authorized or made any distribution upon or with respect
to any class or series of its capital stock or equity; (ii) incurred any Indebtedness individually in excess of $50,000 or, in
the case of Indebtedness individually less than $50,000, in excess of $100,000 in the aggregate; (iii) made any loans or advances
to any Person not in excess, individually or in the aggregate, of $100,000, other than ordinary course advances for travel expenses;
or (iv) sold, exchanged or otherwise disposed of any of its assets or rights, other than the sale of its inventory in the ordinary
course of business; and as of the date of this Agreement, no Company nor any of its Subsidiaries has any outstanding Indebtedness.
For purposes of this Agreement, “Indebtedness” of any Person means, without duplication: (a) all Indebtedness for borrowed
money; (b) all obligations issued, undertaken or assumed as the deferred purchase price of property or services, including earn-outs
(other than accrued expenses incurred in the ordinary course of business and trade payables entered into in the ordinary course
of business); (c) the face amount of all letters of credit issued for the account of such Person and without duplication, all drafts
drawn thereunder and all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar
instruments issued by such Person; (d) all obligations evidenced by notes, bonds, debentures or similar instruments, including
obligations so evidenced incurred in connection with the acquisition of property, assets or businesses; (e) all Indebtedness created
or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect
to property acquired by the Person (even though the rights and remedies of the seller or bank under such agreement in the event
of default are limited to repossession or sale of such property); (f) all Capital Lease Obligations; (g) the principal balance
outstanding under any synthetic lease, off-balance sheet loan or similar off balance sheet financing product; (h) all obligations,
whether or not contingent, to purchase, redeem, retire, defease or otherwise acquire for value any of its own stock or stock equivalents
(or any stock or stock equivalent of a direct or indirect parent entity thereof) prior to the date that is 180 days after the Maturity
Date, valued at, in the case of redeemable preferred stock, the greater of the voluntary liquidation preference and the involuntary
liquidation preference of such stock plus accrued and unpaid dividends; (i) all Indebtedness referred to in clauses (a) through
(h) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured
by) any Lien upon or in property (including accounts and contracts rights) owned by such Person, even though such Person has not
assumed or become liable for the payment of such Indebtedness (and for purposes of this Agreement, if such Person is not liable
for the payment of such Indebtedness, the amount of Indebtedness of such Person shall be deemed to be the fair market value of
such property); and (j) all Contingent Obligations in respect of Indebtedness or obligations of others of the kinds referred to
in clauses (a) through (i) above. As used in this Agreement, “Capital Lease Obligation” means, as to any Person,
any obligation that is required to be classified and accounted for as a capital lease on a balance sheet of such Person prepared
in accordance with GAAP (as defined below), and the amount of such obligation shall be the capitalized amount thereof, determined
in accordance with GAAP; and “Contingent Obligation” means, as to any Person, any direct or indirect liability,
contingent or otherwise, of that Person with respect to any indebtedness, lease, dividend or other obligation of another Person
if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance
to the obligee of such liability that such liability will be paid or discharged, or that any agreements relating thereto will be
complied with, or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto.

 

    	 	8	 

     

    

  

(c)          For
the purposes of subsections (a) and (b) above, all Indebtedness, liabilities, agreements, understandings, instruments, contracts
and proposed transactions involving the same Person (including Persons any Company or any Subsidiary of any Company has reason
to believe are affiliated therewith) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such
subsections.

 

6.7           Internal
Accounting Controls; Disclosure Controls and Procedures. Each Company and each
of its Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions
are executed in accordance with management’s general or specific authorizations, (ii) except as respects BST and WE
SELL prior to the Initial Closing Date, transactions are recorded as necessary to permit preparation of financial statements in
conformity with United States generally accepted accounting principles (“GAAP”) and to maintain asset and liability
accountability, (iii) access to assets or incurrence of liability is permitted only in accordance with management’s
general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with the existing
assets and liabilities at reasonable intervals and appropriate action is taken with respect to any differences. Since January
1, 2010, USELL has timely filed (taking into account any extensions of such time frames permitted by Rule 12b-25 under the Exchange
Act pursuant to timely filed Forms 12b-25) and made publicly available on the Security and Exchange Commission’s (the “SEC”)
Electronic Data Gathering, Analysis, and Retrieval system (or the successor thereto) (“EDGAR”) system, all
certifications and statements required by (A) Rule 13a-14 or Rule 15d-14 under the Securities Exchange Act of 1934,
as amended (the “Exchange Act”) and (B) Section 906 of Sarbanes Oxley with respect to any SEC Documents
(as defined below). USELL maintains disclosure controls and procedures required by Rule 13a-15 or Rule 15d-15 under
the Exchange Act; such controls and procedures are effective to ensure that the information required to be disclosed by USELL
in the reports that it files with or submits to the SEC (x) is recorded, processed, summarized and reported accurately within
the time periods specified in the SEC’s rules and forms and (y) is accumulated and communicated to USELL’s management,
including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding
required disclosure. USELL maintains internal control over financial reporting required by Rule 13a-15 or Rule 15d-15
under the Exchange Act; such internal control over financial reporting is effective and does not contain any material weaknesses
or significant deficiencies.

 

    	 	9	 

     

    

  

6.8          SEC
Documents; Financial Statements; Sarbanes-Oxley.

 

(a)          Since
January 1, 2010, USELL has filed all reports, schedules, forms, statements and other documents required to be filed by it with
the SEC pursuant to the reporting requirements of the Exchange Act (all of the foregoing filed prior to the date this representation
is made (including all exhibits included therein and financial statements and schedules thereto and documents incorporated by reference
therein) being hereinafter referred to as the “SEC Documents”). USELL has made available to Purchasers or their
respective representatives, or filed and made publicly available on EDGAR no less than five (5) days prior to the date this representation
is made, true and complete copies of the SEC Documents. Except as set forth on Schedule 6.8, each of the SEC Documents was
filed with the SEC within the time frames prescribed by the SEC for the filing of such SEC Documents (including any extensions
of such time frames permitted by Rule 12b-25 under the Exchange Act pursuant to timely filed Forms 12b-25) such that each filing
was timely filed (or deemed timely filed pursuant to Rule 12b-25 under the Exchange Act) with the SEC. Except as set forth in Schedule
6.8, as of their respective dates, the SEC Documents complied in all material respects with the requirements of the Exchange
Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents. Except as set forth in Schedule
6.8, none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light
of the circumstances under which they were made, not misleading. Since the filing of the SEC Documents, except as set forth on
Schedule 6.8, no event has occurred that would require an amendment or supplement to any of the SEC Documents and as to
which such an amendment has not been filed and made publicly available on the SEC’s EDGAR system no less than five (5) days
prior to the date this representation is made. Except as set forth on Schedule 6.8, USELL has not received any written comments
from the SEC staff that have not been resolved to the satisfaction of the SEC staff.

 

(b)          USELL
will file its annual report on Form 10-K for the year ended December 31, 2015 (the “2015 Form 10-K”) by no later
than April 15, 2016, which is within the time frame prescribed by the SEC for the filing thereof (including the extension of such
time frame permitted by Rule 12b-25 under the Exchange Act pursuant to a timely filed Form 12b-25) such that the 2014 Form 10-K
will be deemed timely filed with the SEC pursuant to Rule 12b-25 under the Exchange Act. The 2015 Form 10-K will comply in all
material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated thereunder applicable
to the 2015 Form 10-K, and will not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading.

 

    	 	10	 

     

    

  

(c)          As
of their respective dates, the consolidated financial statements of Companies and their Subsidiaries included in the SEC Documents
(or to be included in the 2015 Form 10-K) complied (or will comply, as applicable) as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have
been prepared in accordance with GAAP, consistently applied, during the periods involved (except (i) as may be otherwise indicated
in such financial statements or the notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may
be subject to normal year-end adjustments, may exclude footnotes or may be condensed or summary statements) and fairly present
in all material respects the financial position of USELL as of the dates thereof and the results of its operations and cash flows
for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). No Company, its
Subsidiaries and their respective officers, directors and Affiliates or, to any Company’s Knowledge, any equity holder of
any Company has made any filing with the SEC (other than the SEC Documents), issued any press release or made, distributed, paid
for or approved (or engaged any other Person to make or distribute) any other public statement, report, advertisement or communication
on behalf of any Company or any of its Subsidiaries or otherwise relating to any Company or any of its Subsidiaries that contains
any untrue statement of a material fact or omits any statement of material fact necessary in order to make the statements therein,
in the light of the circumstances under which they are or were made, not misleading or has provided any other information to Purchasers,
that contains any untrue statement of a material fact or, with respect to written information, omits to state any material fact
necessary in order to make the statements therein, in the light of the circumstances under which they are or were made, not misleading.
No Company is required to file and will not be required to file any agreement, note, lease, mortgage, deed or other instrument
entered into prior to the date this representation is made and to which any Company or any of its Subsidiaries is a party or by
which any Company or any of its Subsidiaries is bound that has not been previously filed as an exhibit (including by way of incorporation
by reference) to any Company’s reports filed or made with the SEC under the Exchange Act. The accounting firm that expressed
its opinion with respect to the consolidated financial statements included in USELL’s most recently filed annual report on
Form 10-K, and reviewed the consolidated financial statements included in USELL’s most recently filed quarterly report on
Form 10-Q was, and the accounting firm that is expressing its opinion with respect to the consolidated financial statements to
be included in the 2015 Form 10-K is, independent of Companies pursuant to the standards set forth in Rule 2-01 of Regulation S-X
promulgated by the SEC and as required by the applicable rules and guidance from the Public Company Accounting Oversight Board
(United States), and such firm was (or is, as applicable) otherwise qualified to render such opinion under applicable law and the
rules and regulations of the SEC. There is no transaction, arrangement or other relationship between any Company and an unconsolidated
or other off-balance-sheet entity that is required to be disclosed by any Company in its reports pursuant to the Exchange Act that
has not been so disclosed in the SEC Documents prior to the date of this Agreement.

 

(d)          USELL
is in all material respects in compliance with the applicable provisions of the Sarbanes-Oxley Act of 2002, as amended, and the
rules and regulations thereunder (collectively, “Sarbanes-Oxley”).

 

    	 	11	 

     

    

  

(e)          Except
as set forth on Schedule 6.8, no Company nor any of its Subsidiaries nor, to any Company’s Knowledge, any director,
officer or employee, of any Company or any of its Subsidiaries, has received or otherwise obtained any material complaint, allegation,
assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods
of any Company or any of its Subsidiaries or its internal accounting controls, including any complaint, allegation, assertion or
claim that any Company or any of its Subsidiaries has engaged in questionable accounting or auditing practices. No attorney representing
any Company or any of its Subsidiaries, whether or not employed by any Company or any of its Subsidiaries, has reported evidence
of a material violation of securities laws, breach of fiduciary duty or similar violation by any Company or any of its Subsidiaries
or any of their respective officers, directors, employees or agents to any Company’s board of directors or any committee
thereof or to any director or officer of any Company pursuant to Section 307 of Sarbanes-Oxley, and the SEC’s rules and regulations
promulgated thereunder. There have been no internal or SEC investigations regarding accounting or revenue recognition discussed
with, reviewed by or initiated at the direction of the chief executive officer, principal financial officer, the board of directors
or any committee thereof. USELL is not, and never has been, a “shell company” (as defined in Rule 12b-2 under the Exchange
Act), except as set forth on Schedule 6.8.

 

(f)          As
used in this Agreement, the “Company’s Knowledge” and similar language means, unless otherwise specified,
the actual knowledge of any “officer” (as such term is defined in Rule 16a-1 under the Exchange Act) of any Company,
and the knowledge any such officer would be expected to have after reasonable due diligence inquiry.

 

6.9          Obligations
to Related Parties. Except as set forth on Schedule 6.9, there are no obligations of any Company or any of its Subsidiaries
to officers, directors, stockholders, equity holders or employees of any Company or any of its Subsidiaries other than:

 

(a)          for
payment of salary for services rendered and for bonus payments;

 

(b)          reimbursement
for reasonable expenses incurred on behalf of any Company and/or its Subsidiaries;

 

(c)          for
other standard employee benefits made generally available to all employees (including stock option agreements outstanding under
any stock option plan approved by the board of directors and equity holders of any Company and/or any Subsidiary of such Company,
as applicable); and

 

(d)          intercompany
obligations among Companies and each of its Subsidiary’s financial statements.

 

    	 	12	 

     

    

  

Except as described above, or as set forth
on Schedule 6.9, none of the officers, directors or, to the best of such Company’s Knowledge (as defined herein),
other employees or equity holders of any Company or any of its Subsidiaries or any members of their immediate families, are indebted
to any Company or any of its Subsidiaries, individually or in the aggregate, in excess of $50,000 or have any direct or indirect
ownership interest in any firm or corporation with which any Company or any of its Subsidiaries is affiliated or with which such
Company or any of its Subsidiaries has a business relationship, or any firm or corporation which competes with any Company or any
of its Subsidiaries, other than passive investments in publicly traded companies (representing less than one percent (1%) of such
company) which may compete with any Company or any of its Subsidiaries. Except as described above, no officer, director or equity
holder of any Company or any of its Subsidiaries, or any member of their immediate families, is, directly or indirectly, interested
in any material contract with any Company or any of its Subsidiaries and no agreements, understandings or proposed transactions
are contemplated between any Company or any of its Subsidiaries and any such Person. Except as set forth on Schedule 6.9,
no Company nor any of their Subsidiaries is a guarantor or indemnitor of any indebtedness of any other Person.

 

6.10     
  Changes. Since the Measurement Date, except as disclosed on Schedule 6.10, there has
not been:

 

(a)          any
change in the business, assets, liabilities, condition (financial or otherwise), properties, operations or prospects of any Company
or any of its Subsidiaries, which individually or in the aggregate has had, or could reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect;

 

(b)          any
resignation or termination of any key officer, key employee or group of key employees of any Company or any of its Subsidiaries;

 

(c)          any
material change, except in the ordinary course of business, in the contingent obligations of any Company or any of its Subsidiaries
by way of guaranty, endorsement, indemnity, warranty or otherwise;

 

(d)          any
damage, destruction or loss, whether or not covered by insurance, which has had, or could reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect;

 

(e)          any
express waiver by any Company or any of its Subsidiaries of a valuable right or of a material debt owed to it;

 

(f)          any
direct or indirect loans made by any Company or any of its Subsidiaries to any equity holder, employee, officer or director of
any Company or any of its Subsidiaries, other than advances made in the ordinary course of business;

 

(g)          any
material change in any compensation arrangement or agreement with any employee, officer, director or equity holder of any Company
or any of its Subsidiaries;

 

(h)          any
declaration or payment of any dividend or other distribution of the assets of any Company or any of its Subsidiaries;

 

(i)          any
labor organization activity related to any Company or any of its Subsidiaries;

 

    	 	13	 

     

    

  

(j)          any
debt, obligation or liability incurred, assumed or guaranteed by any Company or any of its Subsidiaries, except those for current
liabilities incurred in the ordinary course of business;

 

(k)          any
sale, assignment, transfer, abandonment or other disposition of any patent, trademark, copyright, trade secret or other intangible
asset owned by any Company or any of its Subsidiaries;

 

(l)          any
change in any material agreement to which any Company or any of its Subsidiaries is a party or by which any Company or any of its
Subsidiaries is bound which either individually or in the aggregate has had, or could reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect;

 

(m)          any
other event or condition of any character that, either individually or in the aggregate, has had, or could reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect; or

 

(n)          any
arrangement or commitment by any Company or any of its Subsidiaries to do any of the acts described in subsection (a) through (m)
above.

 

6.11        Title
to Properties and Assets; Liens, Etc. Except as set forth on Schedule 6.11, each Company and each of its Subsidiaries
has good and marketable title to its properties and assets, and good title to its leasehold interests, in each case subject to
no mortgage, lien, pledge, hypothecation, charge, security interest, encumbrance or adverse claim of any kind or any restrictive
covenant, condition, restriction or exception of any kind that has the practical effect of creating a mortgage, lien, pledge, hypothecation,
charge, security interest, encumbrance or adverse claim of any kind (including any of the foregoing created by, arising under
or evidenced by any conditional sale or other title retention agreement, the interest of a lessor with respect to a Capital Lease
Obligation, or any financing lease having substantially the same economic effect as any of the foregoing) (each for the foregoing,
a “Lien”), other than the following (each a “Permitted Encumbrance”):

 

(a)          those
Liens in favor of Agent, for the ratable benefit of the Creditor Parties;

 

(b)          Liens
for taxes or other governmental charges not at the time due and payable, or (if foreclosure, distraint, sale or other similar proceeding
shall not have been initiated) which are being contested in good faith by appropriate proceedings diligently prosecuted, so long
as foreclosure, distraint, sale or other similar proceedings have not been initiated, and in each case for which each Company and
its Subsidiaries maintain adequate reserves in accordance with GAAP in respect of such taxes and charges;

 

(c)          easements,
rights of way, restrictions, minor defects or irregularities in title and other similar Liens arising in the ordinary course of
business and not materially detracting from the value of the property subject thereto and not interfering in any material respect
with the ordinary conduct of the business of any Company or any of its Subsidiaries;

 

    	 	14	 

     

    

  

(d)          Liens
arising in the ordinary course of business in favor of carriers, warehousemen, mechanics and materialmen, or other similar Liens
imposed by law, which remain payable without penalty or which are being contested in good faith by appropriate proceedings diligently
prosecuted, which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto, and in each
case for which adequate reserves in accordance with GAAP are being maintained;

 

(e)          with
respect to Companies and Guarantors, deposits, letters of credit, bank guarantees and pledges of cash in an aggregate amount not
in excess of $200,000 securing (i) obligations in connection with worker’s compensation, unemployment insurance or other
forms of governmental insurance or benefits, (ii) the performance of tenders, statutory obligations, bids, leases, contracts and
other similar obligations (other than for borrowed money), (iii) obligations on letters of credit, surety, bid, performance or
appeal bonds, or (iv) financing of insurance premiums and other insurance obligations; and

 

(f)          Liens
set forth on Schedule 6.11 securing Indebtedness outstanding as of the date of this Agreement, and not to be repaid on the
Initial Closing Date, as set forth on Schedule 6.11, without any refinancing, extension, amendment or other modification
thereof (except to the extent expressly permitted under Section 6.11 to this Agreement).

 

All machinery, equipment, fixtures, vehicles
and other properties owned, leased or used by any Company or any of its Subsidiaries are in good operating condition and repair
and are reasonably fit and usable for the purposes for which they are being used.

 

6.12        Intellectual
Property.

 

(a)          Except
as set forth on Schedule 6.12 hereto, each Company and each of its Subsidiaries owns or possesses sufficient legal rights
to the patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information and other proprietary
rights and processes necessary for its business as now conducted and, to each Company’s Knowledge, as presently proposed
to be conducted (the “Intellectual Property”). There are no settlements or consents, covenants not to sue, non-assertion
assurances, or releases to which any Company or any of its Subsidiaries is bound, which affects its rights to own or use any Intellectual
Property.

 

(b)          Except
as set forth on Schedule 6.12 hereto, the conduct of each Company’s and each of its Subsidiaries’ business as
now conducted, and as presently proposed to be conducted, does not (and will not) result in any infringement or other violation
of the valid Intellectual Property rights of others.

 

(c)          Schedule
6.12 (as such schedule may be amended or supplemented from time to time) sets forth a true and complete list of (i) all registrations
and applications for Intellectual Property owned by each Company and each of its Subsidiaries filed or issued by any Intellectual
Property registry and (ii) all Intellectual Property licenses and which are either material to the business of any Company or relate
to any material portion of any Company’s or any of its Subsidiaries’ inventory, including licenses for standard software
having a replacement value of more than $1,000. None of such Intellectual Property licenses are reasonably likely to be construed
as an assignment of the licensed Intellectual Property to such Company or any of its Subsidiaries.

 

    	 	15	 

     

    

  

(d)          Except
as set forth on Schedule 6.12 hereto, there are no claims pending or, to the best of each Company’s Knowledge, threatened
and no Company nor any of their Subsidiaries has received any other communications alleging that any Company or any of its Subsidiaries
has infringed, diluted, misappropriated, or otherwise violated any Intellectual Property rights of any other Person, nor is any
Company or any of its Subsidiaries aware of any basis therefore.

 

(e)          Except
as set forth on Schedule 6.12 hereto, no Company nor any of their Subsidiaries is aware of any infringement, dilution, misappropriation,
or other violation of its Intellectual Property by any other Person.

 

(f)          Except
as set forth on Schedule 6.12 hereto, no Company nor any of their Subsidiaries utilizes any inventions, trade secrets or
other Intellectual Property of any of its employees, officers, or contractors except for inventions, trade secrets or other Intellectual
Property (i) that is owned by such Company or such Subsidiary as a matter of law, (ii) that is lawfully licensed to such Company
or such Subsidiary, or (iii) that has been rightfully assigned to such Company or such Subsidiary.

 

(g)          Each
Company and its Subsidiaries have timely made all filings and payments with the appropriate foreign and domestic agencies required
to maintain in subsistence all owned and registered Intellectual Property, and no such filing contains any misstatements of fact.
All documentation necessary to maintain and effect each Company’s and its Subsidiaries’ ownership of all owned Intellectual
Property, if acquired from other Persons, has been recorded in the United States Patent and Trademark Office, the United States
Copyright Office and all other applicable official offices.

 

6.13         Compliance
with Other Instruments. No Company nor any of its Subsidiaries is in violation
or default of (x) any term of its certificate or articles of formation, bylaws, operating agreement or similar organizational
document, or (y) any provision of any Indebtedness, mortgage, indenture, contract, agreement or instrument to which it is party
or by which it is bound or of any judgment, decree, order or writ, which violation or default, in the case of this clause (y),
has had, or could reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. The execution,
delivery and performance of and compliance with this Agreement and the Related Agreements to which it is a party, and the issuance
and sale of the Notes by Companies and the Closing Shares by USELL each pursuant hereto and thereto, will not, with or without
the passage of time or giving of notice, result in (i) any violation, or be in conflict with or constitute a default under any
such term or provision, (ii) the creation of any Lien upon any of the properties or assets of any Company or any of its Subsidiaries,
or (iii) the suspension, revocation, impairment, forfeiture or non-renewal of any material permit, license, authorization or approval
applicable to any Company or any of its Subsidiaries, its business or operations or any of its assets or properties.

 

    	 	16	 

     

    

  

6.14        Litigation.
Except as set forth on Schedule 6.14, there is no action, suit, proceeding (whether administrative, judicial or otherwise)
or governmental investigation or arbitration pending or, to any Company’s Knowledge, currently threatened against or affecting
any Company or any of its Subsidiaries that prevents any Company or any of its Subsidiaries from entering into this Agreement
or the other Related Agreements, or from consummating the transactions contemplated hereby or thereby, or which has had, or could
reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect or any change in the current
equity ownership of any Company or any of its Subsidiaries, nor does any Company have any Knowledge that there is any basis to
assert any of the foregoing. The estimated maximum amount of liability or exposure of each Company with respect to each litigation
set forth on Schedule 6.14 does not exceed the amount set forth on Schedule 6.14 with respect thereto. No Company
nor any of their Subsidiaries is a party to or subject to the provisions of any order, writ, injunction, judgment or decree of
any court or Governmental Authority. There is no action, suit, proceeding or investigation by any Company or any of its Subsidiaries
currently pending or which any Company or any of its Subsidiaries intends to initiate which could reasonably be expected to have
a Material Adverse Effect.

 

6.15        Tax
Returns and Payments. Each Company and each of its Subsidiaries has timely filed
all tax returns (federal, state, provincial and local) required to be filed by it. All taxes shown to be due and payable on such
returns, any assessments imposed, and all other taxes due and payable by any Company or any of its Subsidiaries on or before the
Initial Closing Date or Deferred Draw Closing Date, as applicable, have been paid or will be paid prior to the time they become
delinquent. There are no unpaid taxes in any material amount claimed in writing to be due from any Company by the taxing authority
of any jurisdiction and there is no basis for any such claim. Except as set forth on Schedule 6.15, no Company nor any
of their Subsidiaries has been advised:

 

(a)          that
any of its returns, federal, state, provincial or other, have been or are being audited as of the date hereof; or

 

(b)          of
any adjustment, deficiency, assessment or court decision in respect of its federal, state, provincial or other taxes.

 

6.16        Employees.
Except as set forth on Schedule 6.16 or except, in the case of USELL, as disclosed in the Exchange Act Filings, no Company
nor any of their Subsidiaries has any collective bargaining agreements with any of its employees. There is no labor union organizing
activity pending or, to any Company’s Knowledge, threatened with respect to any Company or any of its Subsidiaries. Except
as disclosed in the SEC Documents filed prior to the date of this Agreement, no Company nor any of their Subsidiaries is a party
to or bound by any currently effective employment contract, deferred compensation arrangement, bonus plan, incentive plan, profit
sharing plan, retirement agreement or other employee compensation plan or agreement. To each Company’s Knowledge, no employee
of any Company or any of its Subsidiaries, nor any consultant with whom any Company or any of its Subsidiaries has contracted,
is in violation of any term of any employment contract, proprietary information agreement or any other agreement relating to the
right of any such individual to be employed by, or to contract with, any Company or any of its Subsidiaries because of the nature
of the business to be conducted by any Company or any of its Subsidiaries; and to each Company’s Knowledge the continued
employment by each Company and its Subsidiaries of their present employees, and the performance of each Company’s and its
Subsidiaries’ contracts with its independent contractors, will not result in any such violation. No Company nor any of their
Subsidiaries is aware that any of its employees is obligated under any contract (including licenses, covenants or commitments
of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency that would
interfere with their duties to such Company or any of its Subsidiaries. No Company nor any of its Subsidiaries has received any
notice alleging that such violation has occurred. Except for employees who have a current effective employment agreement with
any Company or any of its Subsidiaries, no employee of any Company or any of its Subsidiaries has been granted the right to continued
employment by any Company or any of its Subsidiaries or to any material compensation following termination of employment with
any Company or any of its Subsidiaries. Except as set forth on Schedule 6.16, no Company has any Knowledge that any officer,
key employee or group of employees intends to terminate his, her or their employment with such Company or any of its Subsidiaries,
nor does any Company or any of its Subsidiaries have a present intention to terminate the employment of any officer, key employee
or group of employees.

 

    	 	17	 

     

    

  

6.17         Registration
Rights and Voting Rights. Except as set forth on Schedule 6.17, no Company
nor any of their Subsidiaries is presently under any obligation, and no Company nor any of their Subsidiaries has granted any
rights, to register any of any Company’s or its Subsidiaries’ presently outstanding equity interests or any of its
equity interests that may hereafter be issued. Except as set forth on Schedule 6.17, to each Company’s Knowledge,
no equity holder of any Company or any of its Subsidiaries has entered into any agreement with respect to the voting of equity
interests of any Company or any of its Subsidiaries.

 

6.18         Compliance
with Laws; Permits. No Company nor any of its Subsidiaries is in violation of any
provision of any applicable statute, rule, regulation, order or restriction of any domestic or foreign government or any instrumentality
or agency thereof in respect of the conduct of its business or the ownership of its properties which has had, or could reasonably
be expected to have, either individually or in the aggregate, a Material Adverse Effect. No governmental orders, permissions,
consents, approvals or authorizations are required to be obtained and no registrations or declarations are required to be filed
in connection with the execution and delivery of this Agreement or any other Related Agreement and the issuance of any of the
Notes or Closing Shares, except such as have been duly and validly obtained or filed on or prior to the Initial Closing Date and
which are set forth on Schedule 6.18. Each Company and each of its Subsidiaries (i) is in compliance with and (ii) has
procured and is now in possession of, all material franchises, licenses, permits and similar authorizations required by any applicable
law or regulation for the operation of its business in each jurisdiction wherein it is now conducting business.

 

    	 	18	 

     

    

  

6.19         Environmental
and Safety Laws. There are no pending actions, suits or proceedings by or before
any arbitrator or Governmental Authority pending, or to the Knowledge of each Company, threatened against such Company or any
of its Subsidiaries under Environmental Law. Each Company and its Subsidiaries (i) are and have been in full compliance with Environmental
Law and have no Knowledge or any material expenditure that will be required to maintain such compliance in the future; (ii) have
not received any notice or claim alleging that they are not in full compliance with or otherwise have liability under Environmental
Law; and (iii) have no Knowledge of any facts or circumstances that could reasonably be expected to form the basis of any such
claim. No Hazardous Materials are present or are used or have been used, stored, or released by any Company or its Subsidiaries,
or to their Knowledge by any other Person, at any property currently owned, or, formerly owned, leased or operated by any Company
or its Subsidiaries or disposed of at any other location by any Company or its Subsidiaries except (1) in compliance with Environmental
Law; and (2) in quantities and under circumstances that would not require investigation or remediation by any Company or its Subsidiaries.
No Company nor any of their Subsidiaries have assumed by contract or by operation of law the liabilities arising under Environmental
Law of any other Person. Each Company and its Subsidiaries have provided to Agent all material reports, audits and assessments
in their possession or control regarding the environmental condition of any property currently or formerly owned or operated by
such Company or any Subsidiary. As used herein, “Environmental Law” means all applicable laws, rules, regulations,
codes, ordinances, orders, decrees, judgments, injunctions, legally binding notices or binding agreements issued, promulgated
or entered into by any Governmental Authority, relating in any way to pollution or the environment , preservation or reclamation
of natural resources, the management, generation, use, handling, treatment, transportation, storage, disposal or release or threatened
release of or exposure to Hazardous Materials, or occupational health and safety, “Governmental Authority”
means any nation or government, any state, province other political subdivision thereof, and any agency, department or other entity
exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government and “Hazardous
Materials” means materials, wastes or pollutants listed or defined as “hazardous materials”, “hazardous
wastes” ,”toxic substances” or by words of similar import or any other substance or waste otherwise regulated
by applicable Environmental Law, including nuclear materials and radioactive substances or wastes, petroleum or petroleum distillates,
asbestos or asbestos containing materials, polychlorinated biphenyls, radon gas, infectious or medical wastes, and toxic mold.

 

6.20         Valid
Offering. Assuming the accuracy of the representations and warranties of Purchasers
contained in this Agreement, the offer, sale and issuance of the Notes and the Closing Shares will be exempt from the registration
requirements of the Securities Act of 1933, as amended (the “Securities Act”), and will have been registered
or qualified (or are exempt from registration and qualification) under the registration, permit or qualification requirements
of all applicable state equity interests laws.

 

6.21         Acknowledgment
Regarding Purchaser’s Purchase of Notes. Each Company further acknowledges that no Credit Party is acting as a financial
advisor or fiduciary of any Company (or in any similar capacity) with respect to this Agreement and the Related Agreements, and
the transaction contemplated hereby and thereby, and any advice given by any Creditor Party or any of their respective representatives
or agents in connection with this Agreement and the Related Agreements, and the transactions contemplated hereby and thereby is
merely incidental to such Purchaser’s purchase of the Notes and the issuance of the Closing Shares. Each Company further
represents to each Creditor Party that such Company’s decision to enter into this Agreement and the Related Agreements has
been based solely on the independent evaluation by each Company and its representatives.

 

6.22         No
Material Adverse Effect; No Undisclosed Liabilities. Except as disclosed in the SEC Documents filed prior to the date of this
Agreement or as set forth on Schedule 6.22, since the Measurement Date, there has been no Material Adverse Effect and no
circumstances exist that could reasonably be expected to be, cause or have a Material Adverse Effect.

 

    	 	19	 

     

    

  

6.23         General
Solicitation. No Company, nor any of its affiliates, nor any Person acting on its or their behalf, has engaged or will engage
in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection
with the offer or sale of the Notes.

 

6.24         No
Integrated Offering. No Company, nor any of its affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require registration
of any of the Notes under the Securities Act, including causing this offering of the Notes to be integrated with prior offerings
by any Company for purposes of the Securities Act such that registration of any of the Notes would be required, nor will any Company
take any action or steps that would require registration of the issuance of any of the Notes under the Securities Act, including
causing the offering of the Notes to be integrated with other offerings for purposes of the Securities Act such that registration
of any of the Notes would be required.

 

6.25         Listing.
USELL is not in violation of any of the rules, regulations or requirements of the OTCQB (the “Principal Market”),
and, to USELL’s Knowledge, there are no facts or circumstances that could reasonably lead to suspension or termination of
trading of any Company’s common stock (the “Common Stock”) on the Principal Market. Since May 6, 2015,
(i) the Common Stock has been listed on the Principal Market, (ii) trading in the Common Stock has not been suspended or deregistered
by the SEC or the Principal Market and (iii) USELL has not received any communication, written or oral, from the SEC or the Principal
Market regarding the suspension or termination of trading of the Common Stock on the Principal Market. USELL satisfies the quantitative
standards for continued listing of the Common Stock on the Principal Market.

 

6.26         Investment
Company. No Company is, and upon each of the Initial Closing Date and the Deferred Draw Closing Date, will not be, an “investment
company,” a company controlled by an “investment company,” or an “affiliated person” of, or “promoter”
or “principal underwriter” for, an “investment company,” as such terms are defined in the Investment Company
Act of 1940, as amended.

 

6.27         No
Disqualification Events. No Company, any of its predecessors, any director, executive officer, other officer of any Company
participating in the offering contemplated hereby, any beneficial owner (as that term is defined in Rule 13d-3 under the Exchange
Act) of 20% or more of any Company’s outstanding voting equity securities, calculated on the basis of voting power, any “promoter”
(as that term is defined in Rule 405 under the Securities Act) connected with any Company in any capacity at the time any closing,
any placement agent or dealer participating in the offering of the Notes, and any of such agents’ or dealer’s directors,
executive officers, other officers participating in the offering of the Notes (each, a “Covered Person” and,
together, “Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in
Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”). Each Company has exercised
reasonable care to determine (i) the identity of each Person that is a Covered Person; and (ii) whether any Covered Person is subject
to a Disqualification Event. Each Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e).
With respect to each Covered Person, each Company has established procedures reasonably designed to ensure that such Company receives
notice from each such Covered Person of (i) any Disqualification Event relating to that Covered Person, and (ii) any event that
would, with the passage of time, become a Disqualification Event relating to that Covered Person; in each case occurring up to
and including any Closing Date. No Company is for any other reason disqualified from reliance upon Rule 506 of Regulation D under
the Securities Act for purposes of the offer and sale of the Notes.

 

    	 	20	 

     

    

  

6.28         Full
Disclosure. Each Company and each of its Subsidiaries has provided Purchasers with
all information requested by Purchasers in connection with Purchasers’ decision to purchase the Notes and Closing Shares,
including all information each Company and its Subsidiaries believe is reasonably necessary to make such investment decision.
Neither this Agreement, the Related Agreements, the exhibits and schedules hereto and thereto nor the responses contained in any
executed final questionnaire provided by Companies to Agent, contain any untrue statement of a material fact nor omit to state
a material fact necessary in order to make the statements contained herein or therein, in light of the circumstances in which
they are made, not misleading. All financial projections and other estimates provided to Purchasers by any Company or any of its
Subsidiaries were based on the applicable Company’s and its Subsidiaries’ experience in the industry and on assumptions
of fact and opinion as to future events which such Company and such Subsidiaries, at the date of the issuance of such projections
or estimates, believed to be reasonable.

 

6.29         Insurance.
Each Company and each of its Subsidiaries has general commercial, product liability, fire and casualty insurance policies with
coverages which such Company and each of its Subsidiaries believe are customary for companies similarly situated to such Company
and its Subsidiaries in the same or similar business.

 

6.30         Dilution.
USELL specifically acknowledges that its obligation to issue the Closing Shares is binding upon USELL and enforceable regardless
of the dilution such issuance may have on the ownership interests of other equity holders of USELL.

 

6.31         Patriot
Act. Each Company certifies that, to the best of such Company’s Knowledge,
no Company nor any of their Subsidiaries has been designated, nor is or shall be owned or controlled, by a “suspected terrorist”
as defined in Executive Order 13224. Each Company hereby acknowledges that each of the Creditor Parties seeks to comply with all
applicable laws concerning money laundering and related activities. In furtherance of those efforts, each Company hereby represents,
warrants and covenants that: (i) none of the cash or property that any Company or any of its Subsidiaries will pay or will contribute
to any Creditor Party has been or shall be derived from, or related to, any activity that is deemed criminal under United States
law; and (ii) no contribution or payment by any Company or any of its Subsidiaries to any Creditor Party, to the extent that they
are within such Company’s and/or its Subsidiaries’ control shall cause any Creditor Party to be in violation of the
United States Bank Secrecy Act, the United States International Money Laundering Control Act of 1986, the United States International
Money Laundering Abatement and Anti-Terrorist Financing Act of 2001. Each Company shall promptly notify Agent if any of these
representations, warranties or covenants ceases to be true and accurate regarding any Company or any of its Subsidiaries. Each
Company shall provide any Creditor Party all additional information regarding such Company or any of its Subsidiaries that such
Creditor Party deems necessary or convenient to ensure compliance with all applicable laws concerning money laundering and similar
activities. Each Company understands and agrees that if at any time it is discovered that any of the foregoing representations,
warranties or covenants are incorrect, or if otherwise required by applicable law or regulation related to money laundering or
similar activities, the Creditor Parties may undertake appropriate actions to ensure compliance with applicable law or regulation,
including but not limited to segregation and/or redemption of any Purchaser’s investment in such Company. Each Company further
understands that solely to the extent required by applicable law, the Creditor Parties may release confidential information about
such Company and its Subsidiaries and, if applicable, any underlying beneficial owners, to proper authorities if such Creditor
Party, in its sole discretion, determines that it is in the best interests of such Creditor Party in light of relevant rules and
regulations under the laws set forth in subsection (ii) above.

 

    	 	21	 

     

    

  

6.32         ERISA.
Based upon the Employee Retirement Income Security Act of 1974 (“ERISA”), and the regulations and published interpretations
thereunder: (i) no Company nor any of their Subsidiaries has engaged in any non-exempt Prohibited Transactions (as defined in
Section 406 of ERISA and Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”)); (ii) each Company
and each of its Subsidiaries has met all applicable minimum funding requirements under Section 302 of ERISA in respect of its
ERISA-governed plans; (iii) no Company nor any of their Subsidiaries has any Knowledge of any event or occurrence which would
cause the Pension Benefit Guaranty Corporation to institute proceedings under Title IV of ERISA to terminate any employee benefit
plan(s); (iv) no Company nor any of their Subsidiaries has any fiduciary responsibility for investments with respect to any plan
existing for the benefit of Persons other than such Company’s or such Subsidiary’s employees and their beneficiaries;
and (v) no Company nor any of their Subsidiaries has withdrawn, completely or partially, from any multi-employer pension plan
so as to incur liability under the Multiemployer Pension Plan Amendments Act of 1980.

 

6.33         Status
of Certain Subsidiaries. Neither Money4Gold, Inc. nor Money4Gold Precious Metals, Inc. engages in any business activities and
does not own any property or assets. No later than sixty (60) days of the Initial Closing Date, Companies shall provide Agent with
evidence that each of Money4Gold, Inc. and Money4Gold Precious Metals, Inc. have been legally dissolved.

 

7.    
      Representations and Warranties of each Purchaser. Each Purchaser hereby
represents and warrants, severally and not jointly, to Companies as follows:

 

7.1           Organization,
Good Standing and Qualification. Such Purchaser is a corporation duly organized,
validly existing and in good standing under the laws of its jurisdiction of incorporation. Such Purchaser is duly qualified and
is authorized to do business and is in good standing as a foreign corporation in all jurisdictions in which the nature or location
of its activities and of its properties (both owned and leased) makes such qualification necessary, except for those jurisdictions
in which failure to do so has not, or could not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect.

 

7.2           Intentionally
Omitted.

 

    	 	22	 

     

    

  

7.3          Requisite
Power and Authority. Such Purchaser has all necessary power and authority under
all applicable provisions of law to execute and deliver this Agreement and the Related Agreements and to carry out their provisions.
All corporate, limited liability, partnership or trust action on such Purchaser’s part required for the lawful execution
and delivery of this Agreement and the Related Agreements have been taken or will be effectively taken prior to the Initial Closing
Date. Upon their execution and delivery, this Agreement and the Related Agreements will be valid and binding obligations of such
Purchaser, enforceable in accordance with their terms, except:

 

(a)          as
limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement
of creditors’ rights; and

 

(b)          as
limited by general principles of equity that restrict the availability of equitable and legal remedies.

 

7.4          Investment
Representations. Such Purchaser understands that the Notes and Closing Shares are
being offered and sold pursuant to an exemption from registration contained in the Securities Act based in part upon such Purchaser’s
representations contained in this Agreement, including that such Purchaser is an “accredited investor” within the
meaning of Regulation D under the Securities Act. Such Purchaser confirms that it has received or has had full access to all the
information it considers necessary or appropriate to make an informed investment decision with respect to the applicable Notes
and Closing Shares to be purchased by it under this Agreement. Such Purchaser further confirms that it has had an opportunity
to ask questions and receive answers from each Company regarding such Company’s and its Subsidiaries’ business, management
and financial affairs and the terms and conditions of the Offering and the Equity interests and to obtain additional information
(to the extent such Company possessed such information or could acquire it without unreasonable effort or expense) necessary to
verify any information furnished to such Purchaser or to which such Purchaser had access. Neither such inquiries nor any other
due diligence investigations conducted by such Purchaser or its advisors, if any, or its representatives shall modify, amend or
affect such Purchaser’s right to rely on any Company’s representations and warranties contained in Section 6.

 

7.5          Transfer
or Resale. Such Purchaser understands that (i) the Notes have not been and are not being registered under the Securities Act
or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered
thereunder, (B) such Purchaser shall have delivered to any Company an opinion of counsel, in a generally acceptable form, to the
effect that such Notes to be sold, assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such
registration, or (C) such Purchaser provides any Company with reasonable assurance that such Notes can be sold, assigned or transferred
pursuant to Rule 144; (ii) any sale of the Notes made in reliance on Rule 144 may be made only in accordance with the terms of
Rule 144; and (iii) no Company nor any other Person is under any obligation to register the Notes under the Securities Act or any
state securities laws or to comply with the terms and conditions of any exemption thereunder.

 

    	 	23	 

     

    

  

7.6          Purchaser
Bears Economic Risk. Such Purchaser understands that its investment in the Notes
and the Closing Shares involves a high degree of risk. Such Purchaser has sought such accounting, legal and tax advice as it has
considered necessary to make an informed investment decision with respect to its acquisition of the Notes and the Closing Shares.

 

7.7          Acquisition
for Own Account. Such Purchaser is acquiring the applicable Notes and Closing Shares
for such Purchaser’s own account for investment only, and not as a nominee or agent and not with a view towards or for resale
in connection with their distribution, except pursuant to sales registered under, or exempted from, the registration requirements
of, the Securities Act; provided, however, that by making the representations herein, such Purchaser does not agree to hold any
of the Notes for any minimum or other specific term and reserves the right to dispose of the Notes at any time in accordance with
or pursuant to a registration statement or an exemption under the Securities Act.

 

7.8          Purchaser
Can Protect Its Interest. Such Purchaser represents that by reason of its, or of
its management’s, business and financial experience, such Purchaser has the capacity to evaluate the merits and risks of
its investment in the Notes and Closing Shares and to protect its own interests in connection with the transactions contemplated
in this Agreement and the Related Agreements.

 

7.9          Accredited
Investor. Such Purchaser represents that it is an accredited investor within the
meaning of Regulation D under the Securities Act. As of the Initial Closing Date, Purchasers collectively have the sufficient
liquidity to purchase the Deferred Draw Notes.

 

7.10        Legends.

 

(a)          The
applicable Notes shall bear substantially the following legend (the “Securities Act Legend”):

 

“THIS NOTE HAS NOT BEEN REGISTERED
UNDER THE SECURITIES OF 1933, AS AMENDED, OR APPLICABLE STATE EQUITY INTERESTS LAWS. THIS NOTE MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED, PLEDGED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES OR (B) AN
OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES
LAWS OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.”

 

(b)          The
applicable Closing Shares, if not issued by DWAC system (as hereinafter defined), shall bear a legend which shall be in substantially
the following form until such shares are covered by an effective registration statement filed with the SEC:

 

    	 	24	 

     

    

  

“THESE SHARES HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE EQUITY INTERESTS LAWS. THESE SHARES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED, PLEDGED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE
SECURITIES LAWS OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.”

 

8.    
      Covenants of Companies. Each Company covenants and agrees with each
Creditor Party as follows:

 

8.1          Stop-Orders.
USELL will, by written notice, advise Agent, promptly after it receives notice of issuance by the SEC, any state equity interests
commission or any other regulatory authority of any stop order or of any order preventing or suspending any offering of any equity
interests of USELL, of the suspension of the qualification of the Common Stock for offering or sale in any jurisdiction, or the
initiation of any proceeding for any such purpose.

 

8.2          Listing.
USELL will maintain the listing or quotation, as applicable, of its Common Stock on the Principal Market, and will comply in all
material respects with USELL’s reporting, filing and other obligations under the bylaws or rules of the Financial Industry
Regulatory Authority (“FINRA”) and such exchanges, as applicable.

 

8.3          Market
Regulations. Such Company shall notify the SEC and applicable state authorities,
in accordance with their requirements, of the transactions contemplated by this Agreement, and shall take all other necessary
action and proceedings as may be required and permitted by applicable law, rule and regulation, for the legal and valid issuance
of the Notes and Closing Shares to each Purchaser and promptly provide copies thereof to such Purchaser.

 

8.4          Reporting
Requirements. Such Company will deliver, or cause to be delivered, to Agent each
of the following:

 

(a)          as
soon as available, but not later than 105 days after the end of each fiscal year of each Company, a copy of the audited consolidated
balance sheet and related statements of operations, shareholders’ equity and cash flows of such Company and its Subsidiaries
and the Consolidating Financial Statement for such year) as of the end of and for such year, setting forth in each case in comparative
form the figures for the previous fiscal year, all reported on by independent public accountants approved by Agent (without a “going
concern” or like qualification or exception and without any qualification or exception as to the scope of such audit) to
the effect that such consolidated and consolidating financial statements present fairly in all material respects the financial
condition and results of operations of such Company and its Subsidiaries on a consolidated and consolidating basis in accordance
with GAAP consistently applied. As used in this Agreement, “Consolidating Financial Statements” means a consolidating
balance sheet and related consolidating statements of operations (in each case with a separate column for each Company, Guarantors
on a combined basis, consolidating adjustments and the total consolidated amounts) as of the applicable date and for the applicable
periods;

 

    	 	25	 

     

    

  

(b)          as
soon as available, but in any event in accordance with then applicable law and not later than 50 days after the end of each of
the first three fiscal quarters of each fiscal year of each Company, a copy of the consolidated and consolidating balance
sheet and related statements of operations, shareholders’ equity and cash flows of such Company and its Subsidiaries as of
the end of and for such fiscal quarter and the then elapsed portion of the fiscal year, and if applicable setting forth in each
case in comparative form the figures for the corresponding period or periods of (or, in the case of the balance sheet, as of the
end of) the previous fiscal year, all certified by the principal financial officer of such Company as presenting fairly in all
material respects the financial condition and results of operations of such Company and its Subsidiaries on a consolidated and
consolidating basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments and the absence
of footnotes;

 

(c)          concurrently
with the financial statements furnished pursuant to subsections (a) and (b) of this Section, an officer’s certificate signed
by the principal financial officer of each Company which compliance certificate shall be reasonably satisfactory to Agent, certifying
such financial statements, such Company’s compliance with the terms of this Agreement and the Related Agreements, certifying
that no Default or Event of Default has occurred under this Agreement or the Related Agreements, and setting forth computations
in reasonable detail showing whether or not as at the end of such fiscal period there existed any breach or violation of any of
the provisions of Section 8.23;

 

(d)          within
60 days prior to the end of each fiscal year, (beginning with the fiscal year ending December 31, 2015), a detailed annual budget
and capital expenditure program for the ensuing year on a monthly basis, including consolidated and consolidating balance sheets
and income and cash flow statements with respect to such period, all certified by the principal financial officer of each Company;

 

(e)          as
soon as practicable following receipt thereof, copies of all environmental audits and reports, whether prepared by personnel of
any Company, its Subsidiaries or by independent consultants, with respect to a significant environmental matter at any premises,
or which relate to an environmental claim which would reasonably be expected to result in a Material Adverse Effect. Any Company
will also promptly advise Agent in writing and in reasonable detail of (i) any Company’s Knowledge of any release of any
Hazardous Material required to be reported to any federal, state or local governmental or regulatory agency under any applicable
Environmental Laws, (ii) any and all written communications received by any Company with respect to any environmental claims that
have a reasonable possibility of giving rise to a Material Adverse Effect or with respect to any release of Hazardous Material
required to be reported to any Federal, state or local governmental or regulatory agency, (iii) any remedial action taken by any
Company or any other Person in response to (x) any Hazardous Material on, under or about any premises, the existence of which has
a reasonable possibility of resulting in an environmental claim having a Material Adverse Effect or (y) any environmental claim
that is reasonably likely to have a Material Adverse Effect, (iv) any Company’s discovery of any occurrence or condition
on any real property adjoining or in the vicinity of any premises that is reasonably likely to cause such premises or any part
thereof to be subject to any restrictions on the ownership occupancy, transferability or use thereof under any Environmental Laws
which would have a Material Adverse Effect and (v) any request for information from any governmental agency that suggests such
agency is investigating whether any Company or any of its Affiliates may be potentially responsible for a release of Hazardous
Material;

 

    	 	26	 

     

    

  

(f)          promptly,
but in no event later than 3 business days after any officer, director or employee of any Company or any Subsidiary obtaining actual
knowledge of (A) the institution of any Litigation that (i) if adversely determined, has a reasonable possibility of exceeding
$400,000 in damages; or (ii) seeks to enjoin or otherwise prevent the consummation of, or to recover any damages or obtain relief
as a result of, the transactions contemplated hereby; and

 

(g)          upon
Agent’s request of same such other information and/or certification from management of any Company as any Creditor Party
shall request from time to time.

 

8.5          Form
D and Blue Sky. USELL agrees to timely file a Form D with respect to the Notes and the Closing Shares as required under Regulation
D and to provide a copy thereof to each Purchaser promptly after such filing. Each Company shall, on or before each of the Initial
Closing Date and the Delayed Draw Closing Date, take such action as any Company shall reasonably determine is necessary in order
to obtain an exemption for, or to qualify the Notes and the Closing Shares for, sale to Purchaser’s at the closing occurring
on such Closing Date pursuant to this Agreement under applicable securities or “Blue Sky” laws of the states of the
United States, and shall provide evidence of any such action so taken to Purchasers on or prior to each of the Initial Closing
Date and Delayed Draw Closing Date, as applicable. USELL shall make all filings and reports relating to the offer and sale of the
Notes required under applicable securities or “Blue Sky” laws of the states of the United States following the Initial
Closing Date and Delayed Draw Closing Date, as applicable.

 

8.6          Reporting
Status.

 

(a)          From
the date of this Agreement until the latest of (i) the first date on which no Notes remain outstanding, (ii) the date on which
the Security Agreement terminates, (iii) the first date on which Purchaser’s no longer own any Notes and (iv) the date that
no Purchaser has any further rights to purchase Deferred Draw Notes (the period ending on such latest date, the “Reporting
Period”), USELL shall timely file all reports required to be filed with the SEC pursuant to the Exchange Act, and USELL
shall not terminate the registration of the Common Stock under the Exchange Act or otherwise terminate its status as an issuer
required to file reports under the Exchange Act, even if the securities laws would otherwise permit any such termination.

 

(b)          With
a view to making available to the holders of the Notes the benefits of Rule 144, USELL agrees to, during the Reporting Period to:
(A) make and keep public information available, as those terms are understood and defined in Rule 144; (B) file with the SEC in
a timely manner all reports and other documents required of USELL under the Exchange Act; and (C) furnish to each holder of Notes
so long as such holder of Notes owns Notes, promptly upon request, (1) a written statement by USELL, if true, that it has complied
with the reporting requirements of Rule 144 and the Exchange Act, (2) a copy of the most recent annual or quarterly report of USELL
and such other reports and documents so filed by USELL if such reports are not publicly available via EDGAR, and (3) such other
information as may be reasonably requested to permit the holders of Notes to sell such Notes pursuant to Rule 144 without registration.

 

    	 	27	 

     

    

  

8.7           Internal
Accounting Controls. During the Reporting Period, each Company shall, and shall cause each of its Subsidiaries to: (i) at all
times keep books, records and accounts with respect to all of such Person’s business activities, in accordance with sound
accounting practices and GAAP consistently applied, (ii) maintain a system of internal accounting controls sufficient to provide
reasonable assurance that (A) transactions are executed in accordance with management’s general or specific authorizations,
(B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset and liability accountability, (C) access to assets or incurrence of liability is permitted only in accordance with management’s
general or specific authorization and (D) the recorded accountability for assets and liabilities is compared with the existing
assets and liabilities at reasonable intervals and appropriate action is taken with respect to any differences, (iii) in the case
of USELL, timely file and make publicly available on EDGAR, all certifications and statements required by (x) Rule 13a-14 or Rule
15d-14 under the Exchange Act and (y) Section 906 of Sarbanes Oxley with respect to USELL SEC Documents, (iv) maintain disclosure
controls and procedures required by Rule 13a-15 or Rule 15d-15 under the Exchange Act, (v) cause such disclosure controls and procedures
to be effective at all times to ensure that the information required to be disclosed by USELL in the reports that it files with
or submits to the SEC (I) is recorded, processed, summarized and reported accurately within the time periods specified in the SEC’s
rules and forms and (II) is accumulated and communicated to USELL’s management, including its principal executive officer
and principal financial officer, as appropriate to allow timely decisions regarding required disclosure, (vi) maintain internal
control over financial reporting required by Rule 13a-14 or Rule 15d-14 under the Exchange Act, and (vii) cause such internal control
over financial reporting to be effective at all times and not contain any material weaknesses.

 

8.8           Listing.
USELL shall take all actions necessary to remain eligible for quotation of its securities on the Principal Market. USELL shall
not, and shall cause each of its Subsidiaries not to, take any action which would be reasonably expected to result in the suspension
or termination of trading of the Common Stock on the Principal Market. USELL shall pay all fees and expenses in connection with
satisfying its obligations under this Section 8.8.

 

8.9           Disclosure
of Transactions. On or prior to 8:00 a.m. (New York City time) on the second (2nd) business day following each of the Initial
Closing Date or the Deferred Draw Closing Date, as applicable, USELL shall file a Form 8-K with the SEC describing the terms of
the transactions contemplated by this Agreement and the Related Agreements and including (or incorporating by reference in the
case of the Form 8-K following the Deferred Draw Closing Date) as exhibits to such Form 8-K this Agreement and the Related Agreements
(the “Form 8-K Filing”). USELL shall provide Agent and the other Creditor Parties a reasonable opportunity to
review the Form 8-K Filing prior to the filing thereof.

 

    	 	28	 

     

    

  

8.10        Disqualification
Events. USELL will notify Purchasers in writing, prior to each of the Initial Closing Date or the Deferred Draw Closing Date,
as applicable, of (i) any Disqualification Event relating to any Covered Person and (ii) any event that would, with the passage
of time, become a Disqualification Event relating to any Covered Person.

 

8.11        No
Integrated Offering. Neither USELL nor any of its Subsidiaries, nor any Affiliates of the foregoing or any Person acting on
the behalf of any of the foregoing, shall, directly or indirectly, make any offers or sales of any security or solicit any offers
to purchase any security, under any circumstances that would require registration of any of the Notes under the Securities Act,
including causing the offering of the Notes to be integrated with other offerings by any Company for purposes of the Securities
Act such that any of the Notes would be required to be so registered.

 

8.12        Use
of Funds. Each Company shall use the proceeds of the sale of the Initial Notes
for the uses listed on Schedule 8.12. Each Company shall use the proceeds of the sale of the Deferred Draw Notes, if any,
for working capital and other corporate purposes.

 

8.13        Access
to Facilities. Each Company and each of its Subsidiaries will permit any representatives
designated by Agent (or any successor of Agent), upon reasonable notice and during normal business hours, at such Person’s
expense and accompanied by a representative of such Company or any Subsidiary (provided that no such prior notice shall be required
to be given and no such representative of such Company or any Subsidiary shall be required to accompany Agent in the event Agent
believes such access is necessary to preserve or protect the Collateral (as defined in each of the Security Agreement and each
other security agreement entered into by Companies and/or any of its Subsidiaries for the benefit of any of the Creditor Parties)
or following the occurrence and during the continuance of an Event of Default, to:

 

(a)          visit
and inspect any of the properties of such Company or any of its Subsidiaries;

 

(b)          examine
the corporate and financial records of such Company or any of its Subsidiaries (unless such examination is not permitted by federal,
state or local law or by contract) and make copies thereof or extracts therefrom; and

 

(c)          discuss
the affairs, finances and accounts of such Company or any of its Subsidiaries with the directors, officers and independent accountants
of such Company or any of its Subsidiaries.

 

Any Company will hold a regularly scheduled
operations meeting with Agent at least monthly. Any of such meetings may be held telephonically.

 

    	 	29	 

     

    

  

8.14        Taxes.

 

(a)          Each
Company and each of its Subsidiaries will promptly pay and discharge, or cause to be paid and discharged, when due and payable,
all taxes, assessments and governmental charges or levies imposed upon the income, profits, property or business of such Company
and its Subsidiaries; provided, however, that any such tax, assessment, charge or levy need not be paid currently if (i) the validity
thereof shall currently and diligently be contested in good faith by appropriate proceedings and (ii) if such Company and/or such
Subsidiary shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP; and provided, further,
that such Company and its Subsidiaries will pay all such taxes, assessments, charges or levies forthwith upon the commencement
of proceedings to foreclose any lien which may have attached as security therefor.

 

(b)          All
payments made by any Company under this Agreement or any Notes shall be made free and clear of, and without deduction or withholding
for or on account of, any present or future Taxes (as defined below) now or hereafter imposed, levied, collected, withheld or assessed
by any Governmental Authority, other than Excluded Taxes (as defined below). If any Non-Excluded Taxes (as defined below) or Other
Taxes (as defined below) are required to be withheld from any amounts payable to any Creditor Party under this Agreement or any
Notes, the amounts so payable to such Creditor Party shall be increased to the extent necessary to yield to such Creditor Party
(after payment of all Non-Excluded Taxes and Other Taxes, including those imposed on payments made pursuant to this paragraph (b)
of this Section 8.14 or any such other amounts payable in this Agreement or any Notes at the rates or in the amounts specified
herein or therein), an amount equal to the sum it would have received had no such withholding or deductions been made provided,
however, that no Company shall be required to increase any such amounts payable to any Creditor Party with respect to any Non-Excluded
Taxes that are directly attributable to such Creditor Party’s failure to comply with the requirements of paragraph (e) of
this Section 8.14.

 

(c)          In
addition, each Company shall pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.

 

(d)          Whenever
any Non-Excluded Taxes or Other Taxes are payable by any Company as promptly as possible thereafter, such Company shall send to
Agent for its own account or for the account of the relevant Purchaser, as the case may be, a certified copy of an original official
receipt received by such Company showing payment thereof (or such other evidence reasonably satisfactory to Agent). If any Company
fails to pay any Non-Excluded Taxes or Other Taxes when due to the appropriate taxing authority or fails to remit to Agent the
required receipts or other required documentary evidence, each Company shall indemnify the Creditor Parties for any incremental
taxes, interest or penalties that may become payable by any Creditor Party as a result of any such failure.

 

(e)          Each
Purchaser (or its assignee) that is not a “United States Person” as defined in Section 7701(a)(30) of the Code (a “Non-U.S.
Purchaser”) shall deliver to Companies and Agent two completed originals of an appropriate U.S. Internal Revenue Service
Form W-8, as applicable, or any subsequent versions thereof or successors thereto, properly completed and duly executed by such
Non-U.S. Purchaser. Such forms shall be delivered by each Non-U.S. Purchaser on or before the date it becomes a party to this Agreement.
In addition, each Non-U.S. Purchaser shall deliver such forms promptly upon the obsolescence or invalidity of any form previously
delivered by such Non-U.S. Purchaser. Each Non-U.S. Purchaser shall promptly notify Companies at any time it determines that it
is no longer in a position to provide any previously delivered certificate to Companies (or any other form of certification adopted
by the U.S. taxing authorities for such purpose). Notwithstanding any other provision of this paragraph (e), a Non-U.S. Purchaser
shall not be required to deliver any form pursuant to this paragraph that such Non-U.S. Purchaser is not legally able to deliver.

 

    	 	30	 

     

    

  

(f)          The
agreements in the preceding paragraphs (b), (c), (d), (e) and this paragraph (f) shall survive the termination of this Agreement
and the payment of the Notes and all other amounts payable hereunder or thereunder or under any other Related Agreement.

 

As used in this Section
8.14, the following terms shall have the following meanings (such meanings to be equally applicable to both the singular and plural
forms of the terms defined):

 

“Excluded Taxes”
means, with respect to any Creditor Party, taxes imposed on or measured by its overall net income and franchise taxes imposed on
it in lieu of net income taxes, by the jurisdiction (or any political subdivision thereof) under the laws of which such Creditor
Party is incorporated or organized or by the jurisdiction (or any political subdivision thereof) in which the principal place of
management or applicable lending office of such Creditor Party is located.

 

“Non-Excluded
Taxes” means all Taxes other than (i) Excluded Taxes and (ii) Other Taxes.

 

“Other Taxes”
means any and all present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies
arising from any payment made hereunder or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement
or any other Related Agreement.

 

“Taxes”
means any and all present or future taxes, duties, levies, imposts, deductions, assessments, fees, withholdings or similar charges,
and all liabilities with respect thereto.

 

8.15        Insurance.

 

(a)          Each
Company shall bear the full risk of loss from any loss of any nature whatsoever with respect to the Collateral and each Company
and each of its Subsidiaries will, jointly and severally, bear the full risk of loss from any loss of any nature whatsoever with
respect to the assets pledged to Agent, for the ratable benefit of the Creditor Parties, as security for the Liabilities. Furthermore,
each Company will insure or cause the Collateral to be insured against loss or damage by fire, flood, sprinkler leakage, theft,
burglary, pilferage, loss in transit and other risks customarily insured against by companies in similar business similarly situated
as such Company and its Subsidiaries including but not limited to workers compensation, public and product liability and business
interruption, and such other hazards in amounts and under insurance policies and bonds by insurers consistent with current practice
and reasonably acceptable to Agent. Agent shall be named as additional insured and lender loss payee pursuant to endorsements in
form and substance satisfactory to Agent. All premiums thereon shall be paid by such Company, the policies shall be delivered to
Agent if requested by Agent and each such policy shall be endorsed in Agent’s name as an additional insured and lender loss
payee, with an appropriate loss payable endorsement by each Company in form and substance satisfactory to Agent. If any Company
or any of its Subsidiaries fails to obtain the insurance and in such amounts of coverage as otherwise required pursuant to this
Section 8.15, Agent may procure such insurance and the cost thereof shall be promptly reimbursed by Companies and shall constitute
Liabilities.

 

    	 	31	 

     

    

  

(b)          No
Company’s insurance coverage shall be impaired or invalidated by any act or neglect of any Company or any of their Subsidiaries
and the insurer will provide Agent with no less than thirty (30) days’ notice prior of cancellation;

 

(c)          Agent,
in connection with its status as a lender loss payee, will be assigned at all times to a first lien position until such time as
all the Liabilities have been indefeasibly satisfied in full.

 

8.16        Intellectual
Property.

 

(a)          Each
Company, each Guarantors and each of its respective Subsidiaries shall maintain in full force and effect its existence, rights
and franchises and all licenses and other rights to own or use Intellectual Property including registrations and applications therefor,
that are necessary to the conduct of its business, as now conducted or as presently proposed to be conducted, and shall not do
any act or omit to do any act whereby any of such Intellectual Property may lapse, or become abandoned, dedicated to the public,
or unenforceable, or the Lien therein in favor of Agent, for the ratable benefit of the Creditor Parties, would be adversely affected,

 

(b)          Each
Company shall report to Agent (i) the filing by such Company or any Guarantor of any application to register a copyright no later
than ten (10) days after such filing occurs (ii) the filing of any application to register any other Intellectual Property with
any other Intellectual Property, and the issuance thereof, no later than thirty (30) days after such filing or issuance occurs
and, in each case, shall, simultaneously with such report, deliver to Agent fully-executed documents required to acknowledge, confirm,
register, record or perfect the Lien in such Intellectual Property. In addition, each Company and each Guarantor hereby authorize
Agent to modify this Agreement by amending Schedule 6.12 to include any registrations or applications for Intellectual Property
inadvertently omitted from such Schedule or are filed, registered, or acquired by any Company or any Guarantor after the date hereof
and agree to cooperate with Agent in effecting any such amendment to include any new items of Intellectual Property included in
the Collateral.

 

(c)          Such
Company shall, and shall cause each Guarantor to, promptly upon the reasonable request of Agent, execute and deliver to Agent any
document or instrument required to acknowledge, confirm, register, record, or perfect the Lien of Agent in any part of the Intellectual
Property owned by such Company and/or Guarantor.

 

(d)          Except
with the prior written consent of Agent, no Company shall, and no Company shall allow any Guarantor to, sell, assign, transfer,
license, grant any option, or create or suffer to exist any Lien upon or with respect to Intellectual Property, except for the
Permitted Encumbrances.

    	 	32	 

     

    

  

8.17         Properties.
Except as set forth on Schedule 8.17, each Company and each Guarantor will keep its properties in good repair, working
order and condition, reasonable wear, tear and age excepted, and from time to time make all needful and proper repairs, renewals,
replacements, additions and improvements thereto. No Company shall, and shall cause each Guarantor not to, violate, breach or
incur any default under in any respect, or take or fail to take any action that (with or without notice or lapse of time or both)
would constitute a violation or breach of, or default under, any term or provision of, or would result in a reversion of rights
to a Person under, any lease to which any Company or any Guarantor is a party or any other agreement with respect to which any
Company or any Guarantors is a party or otherwise bound or affected, except to the extent such violation, breach or default, action
or inaction could not reasonably be expected, either individually or in the aggregate, to have a Material Adverse Effect.

 

8.18         Confidentiality.
No Company will, and no Company will permit any of its Subsidiaries to, disclose, and will not include in any public announcement,
the name of any Creditor Party, unless expressly agreed to by such Creditor Party or unless and until such disclosure is required
by law or applicable regulation, and then only to the extent of such requirement. Notwithstanding the foregoing, (i) each Company
may disclose any Creditor Party’s identity to its current and prospective debt and equity financing sources, and (ii) each
Company may file copies of this Agreement and the Related Agreements as exhibits as part of the Form 8-K Filing.

 

8.19         Environmental
Matters. Each Company shall, and shall cause each of its Subsidiaries to, comply with, and maintain its real property, whether
owned, leased, subleased or otherwise operated or occupied, in material compliance with, all applicable Environmental Laws (including
by implementing any remedial action necessary to achieve such compliance) or that is required by orders and legally binding directives
of any Governmental Authority.

 

8.20         Compliance
with Laws. Each Company shall, and shall cause each of its Subsidiaries to, comply with all requirements of law of any Governmental
Authority having jurisdiction over it or its business, except where the failure to comply would not reasonably be expected to have,
either individually or in the aggregate, a Material Adverse Effect.

 

8.21         Licenses
and Permits. Each Company shall, and shall cause each of its Subsidiaries to (i) comply with and (ii) procure and maintain
all material licenses or permits required by any applicable law or regulation for the operation of its business in each jurisdiction
wherein it is now conducting business and where the failure to comply with, procure or maintain such licenses or permits would
have a Material Adverse Effect on such Company or any of its Subsidiaries.

 

8.22         Further
Assurances. At any time or from time to time upon the request of any of the Creditor Parties, each Company shall, and shall
cause its Subsidiaries and any third parties, as applicable, at Companies’ expense, to promptly and duly execute, acknowledge
and deliver such further agreements, documents and instruments and do or cause to be done such other acts and things as any of
the Creditor Parties may reasonably request in order to effect fully the purposes of this Agreement and the Related Agreements
and to provide for payment of the obligations hereunder and under the Notes in accordance with the terms of this Agreement, the
Notes and the other Related Agreements. Without limiting the foregoing, each Company shall, and shall cause each of its Subsidiaries
to, at its own respective cost and expense, cause to be promptly and duly taken, executed, acknowledged and delivered all such
further acts, documents and assurances as may from time to time be necessary or as any of the Creditor Parties may from time to
time request in order to establish, create, preserve, protect and perfect a first priority Lien (subject only to Permitted Encumbrances)
in favor of Agent for the benefit of each Creditor Party on the Collateral (including Collateral acquired after the date hereof),
whether now owned or hereafter acquired.

 

    	 	33	 

     

    

  

8.23        Financial
Covenants.

 

(a)          Outstanding
Principal Amount of Loan/EBITDA Ratio. No Company will, at any time, permit the ratio of outstanding principal amount of the
Notes as of the last day of any fiscal quarter to annualized EBITDA during the period set forth below to be greater than the ratio
set forth below for the applicable period (annualized EBITDA shall be determined by multiplying EBITDA for each respective fiscal
quarter by four):

 

	Fiscal Quarter	 	Ratio
	March 31, 2016	 	3.00 to 1.00
	June 30, 2016 and each fiscal quarter thereafter	 	2.00 to 1.00

 

For purposes hereof, “EBITDA”
shall mean, with respect to Companies and their Subsidiaries on a consolidated basis, the net income or loss, plus (i) interest
expense, income taxes (which shall not include any tax that is not measured by or levied upon net income), depreciation and amortization
expense, non-cash equity compensation expense, and to the extent approved by Agent, non-cash extraordinary or non-recurring losses
or expenses (including non-cash impairment charges) (in each case, without duplication, and solely to the extent recognized and
deducted in such fiscal period as an expense in determining such net income), and minus (ii) to the extent recognized and added
in computing net income or loss, without duplication, extraordinary or non-recurring income or gains, all as determined in accordance
with GAAP.

 

(b)          Debt
Coverage Ratio. Companies shall at all times maintain a ratio of (i) the Formula Amount to (ii) Applicable Net Debt greater
than or equal to 1.25 to 1.00. For purposes hereof, (i) “Applicable Net Debt” means, at the date of determination,
the outstanding principal amount of the Notes, (ii) “Formula Amount” means, at the date of determination, the
sum of (A) cash and cash equivalents in the Agent Controlled Account and (B) ninety percent (90%) of the book value of Eligible
Inventory and (iii) “Eligible Inventory” means, at any time of determination, inventory owned by any Company
which is acceptable to Agent in its sole discretion and (A) consists of finished goods but not work in progress, (B) is in good
and saleable condition, (C) is not obsolete, contaminated, unmerchantable, returned, rejected, discontinued or repossessed, (D)
is not in the possession of a processor, consignee or bailee, or located on premises leased or subleased to any Company unless
such processor, consignee, bailee or the lessor or sublessor of such premises, as the case may be, has executed and delivered all
documentation which Agent shall require to evidence the subordination or other limitation or extinguishment of such person’s
or entities’ rights with respect to such inventory and Agent’s right to gain access thereto, (E) does not consist of
fabricated parts, consigned items, supplies or packaging, (F) meets all standards imposed by any governmental authority, (G)
is at all times subject to Lender’s duly perfected, first priority security interest and no other lien or security interest
except as permitted by this Agreement, (H) is situated at a location listed in the Security Agreement, (I) Agent has received a
copy of the purchase order with respect thereto and (J) has not been in any Company’s possession for more than sixty (60)
consecutive days.

 

    	 	34	 

     

    

  

(c)          Debt
Service Coverage Ratio. Beginning with the fiscal quarter ending December 31, 2015 and for each fiscal quarter thereafter,
Companies will not permit the ratio of (i) EBITDA for the three (3) month period preceding the date of determination times four
(4) to (ii) the sum of all principal and interest payments on all Indebtedness made by Companies and Guarantors for the twelve
(12) month period succeeding the date of such determination, to be less than 1.20 to 1.00.

 

(d)          Capital
Expenditures. No Company shall, and shall not permit any Subsidiary to, either make or commit or agree to make any Capital
Expenditure (by purchase or capital lease) during any fiscal quarter, that would cause the aggregate amount of all Capital Expenditures
in such fiscal quarter to exceed $75,000 (excluding the Capital Expenditures for warehouse/facility expansion) not to exceed $300,000);
provided however, that no Capital Expenditures may be made if an Event of Default exists at such time and provided further, that
all assets acquired in connection with any Capital Expenditure will be subject to a perfected first priority lien in favor of Agent.
For purposes of this Agreement, “Capital Expenditures” of any Person means the sum of, without duplication,
(i) all expenditures made directly or indirectly by such Person during such period for equipment, fixed assets, real property or
improvements, or for replacements or substitutes therefor or additions thereto, that have been or should be, in accordance with
GAAP, reflected as additions to property, plant or equipment on a consolidated balance sheet of such Person or have a useful life
of more than one year, plus (ii) the aggregate principal amount of all Indebtedness (including Capital Lease Obligations) assumed
or incurred in connection with such expenditures. For purposes of this definition, the purchase price of equipment that is purchased
simultaneously with the trade-in of existing equipment or with insurance proceeds shall be included in Capital Expenditures only
to the extent the gross amount of such purchase price is greater than the credit granted by the seller of such equipment for the
equipment being traded in at such time or the amount of such proceeds, as the case may be.

 

(e)          Changes
to GAAP. If any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in this
Agreement or any Related Agreement, and either any Company or Agent shall so request, Companies and Agent shall negotiate in good
faith to amend such ratio or requirement to preserve the original intent thereof; provided, until so amended, such ratio or requirement
shall continue to be computed in accordance with GAAP prior to such change.

 

8.24        Required
Approvals. (I) No Company, without the prior written consent of Agent, shall, and
no Company shall permit any of its Subsidiaries to:

 

(a)          (i)
directly or indirectly declare or pay any dividends, other than dividends paid to any Company, (ii) issue any preferred equity
that is mandatorily redeemable prior to the one year anniversary of the Maturity Date or (iii) redeem any of its preferred equity
or other equity interests;

 

    	 	35	 

     

    

  

(b)          liquidate,
dissolve or effect a material reorganization (it being understood that in no event shall any Company or any of their Subsidiaries
dissolve, liquidate or merge with any other Person without the prior written consent of Agent, which consent shall not be unreasonably
withheld);

 

(c)          become
subject to (including, without limitation, by way of amendment to or modification of) any agreement or instrument which by its
terms would (under any circumstances) restrict any Company’s or any of their Subsidiaries, right to perform the provisions
of this Agreement, any Related Agreement or any of the agreements contemplated hereby or thereby;

 

(d)          materially
alter or change the scope of the business of any Company and its Subsidiaries taken as a whole; or

 

(e)          (i)
create, incur, assume or suffer to exist any Indebtedness, whether secured or unsecured, other than (u) Indebtedness not to exceed
$1,000,000 to Scott Tepfers and Brian Tepfer and, provided that any payments with respect thereto shall only be made if (1) no
Event of Default has occurred and is continuing prior to and after giving effect to such payment and (2) after giving effect to
such payment, Companies are in compliance with the financial covenants in Section 8.23 as if such payment had been made in the
fiscal period covered by such financial covenants, (v) any Company’s obligations owed to each Purchaser, (w) Indebtedness
outstanding as of the date of this Agreement, and not required to be repaid on the Initial Closing Date, as set forth on Schedule
8.24 attached hereto and made a part hereof, and any refinancings or replacements thereof that do not (1) increase the principal
amount of such Indebtedness, (2) require additional collateral securing any such Indebtedness or (3) increase the aggregate
interest rate on such Indebtedness by more than 200 bps and so long as such refinancing or replacement is otherwise on terms no
less favorable to Purchasers than the Indebtedness refinanced or replaced, but without any other amendment or modification of any
such Indebtedness, (x) purchase money Indebtedness and Capital Lease Obligations incurred after the date of this Agreement in an
aggregate amount outstanding at any time not to exceed the lesser of (I) $250,000 or (B) three percent (3.00%) of the outstanding
principal balance of the Notes, so long as (A) any lien relating thereto shall only encumber the assets purchased with the purchase
money Indebtedness or subject to the capital leases and no other assets of any Company or any Guarantor, and (B) the principal
amount of any such Indebtedness, when incurred, was not less than 75% nor more than 100% of the then current value of the assets
purchased with the purchase money Indebtedness or subject to the capital leases, (y) insurance premium financing incurred in the
ordinary course of business consistent with past practices, provided such financing is not secured by any assets other than the
insurance so financed and deposits of prepayment of premiums for such insurance and such financing does not exceed $100,000 in
the aggregate at any time, and (z) unsecured account trade payables that are (1) entered into or incurred in the ordinary
course of any Company’s and any Guarantor’s business, and (2) on terms that require full payment within ninety (90)
days from the date entered into or incurred; (ii) create, incur, assume or suffer to exist any Liens of every kind and nature except
(x) Liens securing the Liabilities and (y) Permitted Encumbrances; (iii) assume, guarantee, endorse or otherwise become directly
or contingently liable in connection with any obligations of any other Person (other than any Company or any Guarantor), except
the endorsement of negotiable instruments by any Company or any Guarantor for deposit or collection or similar transactions in
the ordinary course of business or guarantees of Indebtedness otherwise permitted to be outstanding pursuant to this clause (e);
(iv) make any payment or distribution in respect of any subordinated Indebtedness of any Company or its Subsidiaries in violation
of any subordination or other agreement made in favor of any Creditor Party; (v) make any optional payment or prepayment on or
redemption (including by making payments to a sinking fund or analogous fund) or repurchase of any Indebtedness for borrowed money
other than Indebtedness pursuant to this Agreement and other Indebtedness refinanced or replaced as and to the extent permitted
by this clause (e); (vi) sell, exchange, lease or otherwise dispose of any of its assets (including the sale or discount of accounts),
whether by sale, lease or other except (x) for the sale of inventory in the ordinary course of business, (y) for the disposition
or transfer in the ordinary course of business during any fiscal year and of obsolete and worn-out equipment no longer necessary
to the operation of the business of any Company and the sale of personal property that is replaced by equivalent property; (vii)
purchase or otherwise acquire (in one or a series of related transactions) any part of the property or assets (other than purchases
or other acquisitions of inventory in the ordinary course of business) of any Person (or agree to do any of the foregoing at any
future time), (viii) suffer or enter into, or permit any Guarantor to suffer or enter into, any transaction with any affiliate
of any Company or of any Guarantor, except in the ordinary course of business and pursuant to the reasonable requirements of the
business of such Company or such Guarantor upon fair and reasonable terms no less favorable to any Company or any Guarantor than
would be obtained in a comparable arm’s length transaction with a Person not an affiliate of such Company or such Guarantor,
or (ix) directly or indirectly make, or permit any Guarantor to make, any investment in, or any loan, dividend, capital contribution,
distribution or advance to, or any acquisition of any equity or debt securities of, or to otherwise finance, any Person that is
not a Guarantor (other than, with respect to this clause (ix), loans and advances to employees, directors and officers of any Company
or any Guarantor for travel, entertainment, other ordinary business expenses or relocation, in an aggregate amount not to exceed
at any time $100,000); and

 

    	 	36	 

     

    

  

(II)        Any
Company, without the prior written consent of Agent, shall not, and shall not permit any of its Subsidiaries to, create or acquire
any Subsidiary after the date hereof unless (i) such Subsidiary is a wholly-owned Subsidiary of any Company, (ii) such Subsidiary
becomes a party to (A) the Security Agreement (either by executing a counterpart thereof or an assumption or joinder agreement
in respect thereof); (B) the Pledge Agreement (either by executing a counterpart thereof or an assumption or joinder agreement
in respect thereof) or another stock pledge agreement in favor of Purchasers in form and substance satisfactory to Agent (either
by executing a counterpart thereof or an assumption or joinder agreement in respect thereof); (C) an Intellectual Property Security
Agreement in favor of Purchasers in form and substance satisfactory to Agent (either by executing a counterpart thereof or an assumption
or joinder agreement in respect thereof); (D) a Subsidiary Guaranty in favor of Purchasers in form and substance satisfactory to
Agent (either by executing a counterpart thereof or an assumption or joinder agreement in respect thereof) and (iii) to the extent
required by Agent, satisfies each condition of this Agreement and the Related Agreements as if such Subsidiary were a Subsidiary
on the Initial Closing Date.

 

8.25        Reissuance
of Equity Interests. USELL agrees to reissue certificates representing the equity
interests without the legends set forth in Section 7.10 above at such time as:

 

    	 	37	 

     

    

  

(a)          the
holder thereof has sold such equity interests pursuant to Rule 144(b) under the Securities Act; or

 

(b)          upon
resale subject to an effective registration statement after such Equity interests are registered under the Securities Act.

 

USELL agrees to cooperate with Purchasers
in connection with all resales pursuant to Rule 144(b) and Rule 144(d) and provide legal opinions necessary to allow such resales
provided USELL and its counsel receive reasonably requested representations from the applicable Purchasers and broker, if any.

 

8.26        Margin
Stock. No Company will permit any of the proceeds of the Notes or the Closing Shares
to be used directly or indirectly to “purchase” or “carry” “margin stock” or to repay Indebtedness
incurred to “purchase” or “carry” “margin stock” within the respective meanings of each of
the quoted terms under Regulation U of the Board of Governors of the Federal Reserve System as now and from time to time hereafter
in effect.

 

8.27        FIRPTA.
No Company, nor any of its Subsidiaries, is a “United States real property holding corporation” as such term is defined
in Section 897(c)(2) of the Code and Treasury Regulation Section 1.897-2 promulgated thereunder and no Company nor any of its
Subsidiaries shall at any time take any action or otherwise acquire any interest in any asset or property to the extent the effect
of which shall cause such Company and/or such Subsidiary, as the case may be, to be a “United States real property holding
corporation” as such term is defined in Section 897(c)(2) of the Code and Treasury Regulation Section 1.897-2 promulgated
thereunder.

 

8.28        Financing
Right of First Refusal.

 

(a)          Each
Company hereby grants to Purchasers a right of first refusal to provide any Additional Financing (as defined below) to be issued
by any Company and/or any of its Subsidiaries, subject to the following terms and conditions. From and after the date hereof until
the earlier of (i) eighteen (18) months from the Initial Closing Date or (ii) the outstanding principal amount of the Notes is
less than $1,500,000, prior to the incurrence of any additional indebtedness and/or the sale or issuance of any equity interests
of any Company or any of its Subsidiaries in excess of $1,000,000, the proceeds of which are used for the purpose of bulk inventory
purchases (an “Additional Financing”), any Company and/or any Subsidiary of any Company, as the case may be,
shall notify Agent of its intention to enter into such Additional Financing. Additional Financing shall not include capital raised
from registered offerings and equity private placements, including conventional private placements. In connection therewith, any
Company and/or the applicable Subsidiary thereof shall submit a fully executed term sheet (a “Proposed Term Sheet”)
to Agent setting forth the terms, conditions and pricing of any such Additional Financing (such financing to be negotiated on “arm’s
length” terms and the terms thereof to be negotiated in good faith) proposed to be entered into by any Company and/or such
Subsidiary. Agent shall have the right, but not the obligation, to deliver its own proposed term sheet (the “Purchaser
Term Sheet”) setting forth the terms and conditions upon which Purchasers would be willing to provide such Additional
Financing to any Company and/or such Subsidiary. The Purchaser Term Sheet shall contain terms no less favorable to any Company
and/or such Subsidiary than those outlined in the Proposed Term Sheet. Agent shall deliver such Purchaser Term Sheet within ten
(10) business days of receipt of each such Proposed Term Sheet. If the provisions of the Purchaser Term Sheet are at least as favorable
to any Company and/or such Subsidiary, as the case may be, as the provisions of the Proposed Term Sheet, any Company and/or such
Subsidiary shall enter into and consummate the Additional Financing transaction outlined in the Purchaser Term Sheet.

 

    	 	38	 

     

    

  

(b)          No
Company will, and will not permit its Subsidiaries to, agree, directly or indirectly, to any restriction with any Person which
limits the ability of Purchasers to consummate an Additional Financing with any Company or any of its Subsidiaries.

 

8.29        Intentionally
Omitted.

 

8.30        No
Restriction of Additional Financings. No Company will, and will not permit its Subsidiaries to, agree, directly or indirectly,
to any restriction with any Person which limits the ability of Purchasers to consummate an additional financing with any Company
or any of its Subsidiaries.

 

8.31        Changes
to Fiscal Year. No Company will, and will not permit any of its Subsidiaries to, change its fiscal year to end on a date other
than December 31.

 

8.32        Reimbursement
of Monitoring Expenses. Each Company will reimburse Agent and each Purchaser for its reasonable out of pocket expenses incurred
by it in the course of monitoring any Company’s and its Subsidiaries’ compliance with this Agreement and the Related
Agreements and for general, ongoing due diligence while any of the Notes remain outstanding, including reasonable travel expenses.

 

8.33        Limitation
on Amendments to Material Agreements. No Company will, and will not permit any Guarantor to, amend, supplement or otherwise
modify (pursuant to a waiver or otherwise):

 

(a)          the
articles of incorporation, certificate of designation (or corporate charter or other similar organizational document), operating
agreement or bylaws (or other similar document) of any Company or any of its Subsidiaries; or

 

(b)          the
terms and conditions of any material agreements set forth on Schedule 8.33;

 

in each case, in any respect materially
adverse to the interests of any of the Creditor Parties, without the prior written consent of Agent.

 

8.34        Regulatory
Matters. Without providing at least 45 days prior notice to, and obtaining the prior written consent of, Agent, no Company
nor any Subsidiary of any Company shall (a) be or become either of an “electric corporation,” “electric utility”,
“public utility”, “gas utility” or a “gas corporation” under applicable law, or (b) be or become
a “public utility” under the FPA, or a “natural-gas company” under the NGA, or any of a “public-utility
company” or a “holding company” of a “public-utility company” under the Public Utility Holding Company
Act of 1935, as amended.

 

    	 	39	 

     

    

  

8.35         Deposit
Accounts. No Company shall, and not permit any Guarantor, to maintain or establish any new bank accounts other than, as of
the Initial Closing Date, the bank accounts set forth on Schedule 8.35 (which bank accounts constitute all of the deposit
accounts, securities accounts or other similar accounts maintained by each Company and each Guarantor as of the Initial Closing
Date) without prior written notice to Agent and unless Agent and any Company or any Guarantor and the bank or other financial institution
at which the account is to be opened enter into an Account Control Agreement, in form and substance reasonably satisfactory to
Agent, regarding such bank account no later than ten (10) days after the opening of such account.

 

8.36         Post-Closing
Covenant. Any Company and Guarantors shall satisfy the requirements and/or provide to Agent each of the documents, instruments,
agreements and information set forth on Schedule 8.36, in form and substance acceptable to Agent, on or before the
date specified for such requirement in such Schedule or such later date to be determined by Agent in its sole discretion,
each of which shall be completed or provided in form and substance satisfactory to Agent.

 

9.     
     Covenants of Purchasers. Each Purchaser covenants and agrees with Companies as
follows:

 

9.1           Confidentiality.
No Purchaser will disclose, nor will it include in any public announcement, the name of any Company, unless expressly agreed to
by such Company or unless and until such disclosure is required by law or applicable regulation, and then only to the extent of
such requirement.

 

9.2           Non-Public
Information. No Purchaser nor its officers, directors, employees, affiliates, agents,
equity holders and control persons, will effect any sales in the shares of the Common Stock while in possession of material, non-public
information regarding USELL if such sales would violate applicable equity interests law. Agent and each Purchaser agree to keep
confidential the Information (as defined below), except that Agent and each Purchaser shall be permitted to disclose Information
(a) to the extent requested by any Governmental Authority (including any self-regulatory agency having or claiming to have jurisdiction);
(b) to the extent otherwise required by applicable Law or by any subpoena or similar legal process; (c) in connection with the
exercise of any remedies hereunder or in any suit, action or proceeding relating to the enforcement of its rights hereunder or
under any other Related Agreement; (d) to any other party hereto; (e) subject to any agreement containing provisions substantially
the same as set forth in this Section, to any prospective or actual assignees of a Note; or (d) to the extent such Information
(i) is or becomes publicly available other than as a result of a breach of this Section or (ii) is or becomes available to Agent
or any Purchaser on a non-confidential basis from a source other than any Company, any of its Subsidiaries or any of their agents
or representatives. For purposes hereof, “Information” means all information that is received from any Company,
any of its Subsidiaries or any of their agents or representative relating to any Company, any of its Subsidiaries or any of their
respective businesses.

 

    	 	40	 

     

    

 

9.3           Limitation
on Acquisition of Common Stock of USELL. Notwithstanding anything to the contrary
contained in this Agreement, any Related Agreement or any document, instrument or agreement entered into in connection with any
other transactions entered into by a Purchaser and any Company (and/or Subsidiaries or Affiliates of any Company), such Purchaser
(and/or Subsidiaries or Affiliates of such Purchaser) shall not acquire stock in USELL (including, without limitation, pursuant
to a contract to purchase, by exercising an option or warrant, by converting any other security or instrument, by acquiring or
exercising any other right to acquire, shares of stock or other security convertible into shares of stock in USELL, or otherwise,
and such contracts, options, warrants, conversion or other rights shall not be enforceable or exercisable) to the extent such
stock acquisition would cause any interest (including any original issue discount) payable by any Company to a Non-U.S. Purchaser
not to qualify as “portfolio interest” within the meaning of Section 871(h)(2) or Section 881(c)(2) of the Code, by
reason of Section 871(h)(3) or Section 881(c)(3)(B) of the Code, as applicable, taking into account the constructive ownership
rules under Section 871(h)(3)(C) of the Code (the “Stock Acquisition Limitation”). In addition to any other
remedies, if any, available to any Company, if a Purchaser exceeds the Stock Acquisition Limitation, the provisions of Section
6.7(b) shall not apply to payments made to such Purchaser to the extent any additional amounts to be paid thereunder are directly
attributable to the applicable Purchaser exceeding the Stock Acquisition Limitation. The Stock Acquisition Limitation shall automatically
become null and void with respect to a Purchaser, without any notice to any Company, on and after the first date upon which such
Lender and each of its Affiliates which qualify as a Non-U.S. Purchaser no longer owns any indebtedness (including, without limitation,
principal, interest, fees and charges) of any Company.

 

10.         Covenants
of Companies and Purchasers Regarding Indemnification. Each Company agrees to indemnify, hold harmless, reimburse and defend,
on a joint and several basis, each Creditor Party, each of such Creditor Party’s officers, directors, agents, affiliates,
control persons, and principal shareholders, against all claims, costs, expenses, liabilities, obligations, losses or damages (including
reasonable legal fees) of any nature, incurred by or imposed upon such Creditor Party which result, arise out of or are based upon:
(i) any misrepresentation by any Company or any of its Subsidiaries or breach of any warranty by any Company or any of its Subsidiaries
in this Agreement, any Related Agreement or in any exhibits or schedules attached hereto or thereto; (ii) any breach or default
in performance by any Company or any of its Subsidiaries of any covenant or undertaking to be performed by such Company or any
of its Subsidiaries hereunder, under any other Related Agreement or any other agreement entered into by such Company and/or any
of its Subsidiaries and such Creditor Party relating hereto or thereto; or (iii) the status of any Purchaser as a purchaser or
holder of the Notes or any Closing Shares or of Agent as agent thereof.

 

    	 	41	 

     

    

  

11.         Registration
Rights.

 

11.1         Registration
Rights. If at any time after the Closing Date, USELL proposes to
register any of its securities under the Securities Act (other than a registration on Form S-4, Form S-8, or any successor or
similar forms), whether for its own account or otherwise, it will promptly, but not later than twenty (20) days before the anticipated
date of filing such registration statement, give written notice to Agent and all record holders of the Closing Shares. Upon the
written request from any such holders (the “Requesting Holders”), within 15 days after receipt of any such
notice from USELL, USELL will, except as herein provided, cause all of the Closing Shares covered by such request held by the
Requesting Holders to be included in such registration statement, all to the extent requisite to permit the sale or other disposition
by the Requesting Holders of such Closing Shares; provided, further, that nothing herein shall prevent USELL from, at any time,
abandoning or delaying any registration. If any registration pursuant to the preceding sentence shall be underwritten in whole
or in part, USELL may require that the Closing Shares be included in the underwriting on the same terms and conditions as the
securities otherwise being sold through the underwriters. In such event, the Requesting Holders shall, if requested by the underwriters,
execute an underwriting agreement containing customary representations and warranties by selling stockholders. If in the good
faith judgment of the managing underwriter of such public offering the inclusion of all of the requested Closing Shares would
reduce the number of shares to be offered by USELL or interfere with the successful marketing of the shares of stock offered by
USELL, the number of Closing Shares otherwise to be included in the underwritten public offering may be reduced pro rata (by number
of shares) among the Requesting Holders and all other holders of registration rights who have requested inclusion of their securities
or excluded in their entirety if so required by the underwriter.

 

11.2         Offering
Restrictions. Neither USELL nor any of its Subsidiaries will, prior to the repayment
in full of the Notes, (x) enter into any equity line agreement or similar agreement or (y) issue, or enter into any agreement
to issue, any equity interests with a variable/floating conversion and/or pricing feature which are or could be (by conversion
or registration) (commonly known as “floorless convertible instruments”) free-trading equity interests (i.e. common
stock subject to a registration statement).

 

12.         Conditions
Precedent.

 

12.1         Initial
Notes. The obligation of Purchasers to purchase the Initial Notes is subject to the satisfaction of such conditions precedent
before or concurrently with the Initial Closing Date:

 

(i)          Related
Agreements. Agent shall have received from each Company executed originals of this Agreement, the Note and the other Related
Agreements and documents and instruments to be delivered in connection therewith.

 

(ii)         Searches,
Filings, Registrations and Recordings. Agent shall have received copies of UCC, tax lien and judgment searches, or other evidence
satisfactory to Lender, listing all effective financing statements which name each Company and its Subsidiaries (under present
name, any previous name or any trade or doing business name) as debtor and covering all jurisdictions requested by Agent, together
with copies of such other financing statements. Each document (including any UCC financing statement) required by this Agreement,
or any other Related Agreements or under applicable law or reasonably requested by Agent to be filed, registered or recorded in
order to create, in favor of Agent, a perfected first priority security interest (subject to Permitted Encumbrances) in or Lien
upon the Collateral shall have been properly filed, registered or recorded in each jurisdiction in which the filing, registration
or recordation thereof is so required or requested, and Agent shall have received an acknowledgment copy, or other evidence satisfactory
to it, of each such filing, registration or recordation and satisfactory evidence of the payment of any necessary fee, tax or expense
relating thereto.

 

    	 	42	 

     

    

  

(iii)        Corporate
Proceedings. Agent shall have received a copy of the resolutions in form and substance reasonably satisfactory to Agent, of
the board of directors (or equivalent governing body) of each Company and each Guarantor authorizing (i) the execution, delivery
and performance of this Agreement, the Notes and each of the other Related Agreements and (ii) the granting by any Company and
each such Subsidiary of the first priority security interest in and liens upon the Collateral, in each case certified by a senior
executive officer of any Company as of the Initial Closing Date; and, such certificate shall state that the resolutions thereby
certified have not been amended, modified, revoked or rescinded as of the date of such certificate.

 

(iv)        Incumbency
Certificates. Agent shall have received a certificate of the officer of each Company and each Guarantor, dated the Initial
Closing Date, as to the incumbency and signature of the officers of any Company and each Guarantor executing this Agreement, Related
Agreements, any certificate or other documents to be delivered by it pursuant hereto, together with evidence of the incumbency
of such officer.

 

(v)         Organization
Documents. Agent shall have received a copy of all organization documents of each Company and each Guarantor, and all amendments
thereto, certified by the applicable Secretary of State of the jurisdiction of organization and the officer of such company and
the written certification of the officer of such company that no amendment or modification to the organization documents of such
company has become effective since the date on which the organization documents of such company were last delivered to Agent, and
copies of all agreements of the holders of equity interests in such company, certified as accurate and complete by a senior executive
officer of such company.

 

(vi)        Good
Standing Certificates. Agent shall have received good standing certificates for each Company and each Guarantor dated not more
than fifteen (15) days prior to the Initial Closing Date, issued by and each jurisdiction where the conduct of business activities
or the ownership of its properties necessitates qualification.

 

(vii)       Legal
Opinion. Agent shall have received favorable written legal opinions in form and substance satisfactory to Agent, and each Company
and each Guarantor hereby authorizes and directs such counsel to deliver such opinions to Agent and Purchasers.

 

(viii)      No
Litigation. No litigation, investigation or proceeding before or by any arbitrator or Governmental Authority shall be continuing
or threatened against any Company, any of any Company’s Subsidiaries or against any officers or directors of any Company
(A) in connection with this Agreement or any of the Related Agreements or any of the transactions contemplated hereby or thereby
and which, in Agent’s sole and absolute discretion, is deemed material or (B) which could, in Agent’s sole and absolute
discretion, have a Material Adverse Effect; and no injunction, writ, restraining order or other order of any nature materially
adverse to any Company or the conduct of its business or inconsistent with the due consummation of the transactions contemplated
hereby shall have been issued by any Governmental Authority.

 

    	 	43	 

     

    

  

(ix)         Fees
and Expenses. Agent shall have received all fees and expenses payable to it on or prior to the Initial Closing Date.

 

(x)          Insurance.
Agent shall have received in form and substance satisfactory to Agent, (i) copies of any Company’s casualty insurance policies,
together with loss payable endorsements naming Agent as loss payee, and (ii) copies of any Company’s liability insurance
policies, together with endorsements naming Agent as an additional insured.

 

(xi)         Payment
Instructions. Agent shall have received written instructions from any Company directing the application of proceeds of the
issuance of the Initial Notes on the Initial Closing Date.

 

(xii)        Consents.
Agent shall have received any and all consents necessary to permit the effectuation of the transactions contemplated by this Agreement
and any of the Related Agreements. Agent shall have received such third party consents and waivers of such third parties as might
assert claims with respect to the Collateral, as Agent and its counsel shall deem necessary.

 

(xiii)       Releases.
Agent shall have received, in form and substance reasonably satisfactory to it, all releases, terminations and such other documents
as Agent may reasonably request to evidence the repayment of the Indebtedness identified on Schedule 12.1 as to be repaid
on the Initial Closing Date and the termination or release of any Liens, if any, securing such Indebtedness.

 

(xiv)      Solvency
Certificate. Agent shall have received an officer’s certificate of each Company, dated as of the Initial Closing Date,
certifying that each Company and Guarantor, on a consolidated basis, are Solvent after giving effect to the consummation of the
transactions contemplated hereby, such certificate to be in form and substance to the reasonable satisfaction of Agent.

 

(xv)       Officer’s
Certificate. Each Company shall have delivered to Agent a Certificate of such Company, in form and substance satisfactory to
Agent, to the effect that (i) the representations and warranties in this Agreement are true, correct and complete on and as of
the Initial Closing Date, (ii) neither this Agreement nor any of the Related Agreements contains any untrue statement of a material
fact or omits a material fact necessary to make the statements therein not misleading, (iii) such Company shall have performed
all agreements and satisfied all conditions which this Agreement and the other Related Agreements on or before the Initial Closing
Date except as otherwise disclosed to and agreed to in writing by any Company and Agent, and (iv) no Default or Event of Default
shall have occurred and be continuing.

 

    	 	44	 

     

    

  

(xvi)      2015
Budget. Each Company shall have delivered to Agent a detailed annual budget and capital expenditure program for 2015 (from
the Initial Closing Date through December 31, 2015) on a monthly basis, including consolidated balance sheets and income and cash
flow statements with respect to such period, all certified by the principal financial officer of each Company.

 

(xvii)     Employment
Agreements. Agent shall have completed satisfactory review and approval of employment agreements between each Company and each
of the members of senior management of such Company.

 

(xviii)    Due
Diligence. Agent shall have completed its legal and business due diligence, including Collateral examinations, background and
credit checks with respect to each Company, each Guarantor and their respective management, with results satisfactory to Lender

 

(xix)       Quality
Earnings Report. Agent shall have received a copy of the quality of earnings report prepared by an independent third party
satisfactory to Agent with respect to “WeSellCellular.”

 

(xx)        Account
Debtor Notifications. Agent shall have received notification letters executed by each Company and each Guarantor in blank to
account debtors of such Company and Guarantor notifying account debtors that Agent has a security interest in the accounts of each
Company and each Guarantor and directing such account debtors to make payment thereof directly to Agent.

 

12.2         Delayed
Draw Notes. The obligation of each Purchaser to purchase the Deferred Draw Notes shall be subject to the further conditions
precedent that on the Deferred Draw Closing Date, the following statements shall be true (and the giving of the applicable notice
of issuance and issuance by any Company of such Notes to Purchasers shall constitute a representation and warranty by any Company
that both on the date of such notice and on the Deferred Draw Closing Date such statements are true):

 

(i)          Initial
Conditions Precedent. The conditions set forth in Section 12.1 are satisfied;

 

(ii)         Representations
and Warranties. The representations and warranties contained in this Agreement and the Related Agreements are correct in all
material respects on and as of such date, before and after giving effect to such issuance and to the application of the proceeds
therefrom, as though made on and as of such date, other than any such representations or warranties that, by their terms, refer
to a specific date other than the date of such issuance, in which case, as of such specific date; and

 

(iii)        No
Default. No Default or Event of Default has occurred and is continuing, or would result from such issuance or from the application
of the proceeds therefrom.

 

    	 	45	 

     

    

  

(iv)        Good
Standing Certificates. Agent shall have received good standing certificates for each Company and each Guarantor dated not more
than fifteen (15) days prior to the Deferred Draw Closing Date, issued by and each jurisdiction where the conduct of business activities
or the ownership of its properties necessitates qualification.

 

(v)         Officer’s
Certificate. Each Company shall have delivered to Agent a Certificate of any Company, in form and substance satisfactory to
Agent, to the effect that (A) the representations and warranties in this Agreement are true, correct and complete on and as of
the Deferred Draw Closing Date, (B) neither this Agreement nor any of the Related Agreements contains any untrue statement of a
material fact or omits a material fact necessary to make the statements therein not misleading, (C) each Company shall have performed
all agreements and satisfied all conditions which this Agreement and the other Related Agreements on or before the Deferred Draw
Closing Date except as otherwise disclosed to and agreed to in writing by any Company and Agent, and (iv) no Default or Event of
Default shall have occurred and be continuing.

 

(vi)        Legal
Opinion. Agent shall have received favorable written legal opinions in form and substance satisfactory to Agent, and each Company
and each Guarantor hereby authorizes and directs such counsel to deliver such opinions to Agent and Purchasers.

 

(vii)       Fees
and Expenses. Agent shall have received all fees and expenses payable to it on or prior to the Deferred Draw Closing Date.

 

(viii)      Disbursement
Instructions. Agent shall have received written instructions from any Company directing the application of proceeds of the
issuance of the Deferred Draw Notes on the Deferred Draw Closing Date.

 

(ix)         Other.
Any Company shall have delivered such other approvals, opinions or documents as any Creditor Party through Agent shall reasonably
request.

 

13.    
     Miscellaneous.

 

13.1        Governing
Law, Jurisdiction and Waiver of Jury Trial.

 

(a)          THIS
AGREEMENT AND THE OTHER RELATED AGREEMENTS SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE
OF NEW YORK APPLICABLE TO CONTRACTS MADE AND PERFORMED IN SUCH STATE, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAWS.

 

    	 	46	 

     

    

  

(b)          EACH
COMPANY HEREBY CONSENTS AND AGREES THAT THE STATE OR FEDERAL COURTS LOCATED IN THE COUNTY OF NEW YORK, STATE OF NEW YORK SHALL
HAVE EXCLUSIVE JURISDICTION TO HEAR AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN SUCH COMPANY, ON THE ONE HAND, AND ANY CREDITOR
PARTY, ON THE OTHER HAND, PERTAINING TO THIS AGREEMENT OR ANY OF THE RELATED AGREEMENTS OR TO ANY MATTER ARISING OUT OF OR RELATED
TO THIS AGREEMENT OR ANY OF THE OTHER RELATED AGREEMENTS; PROVIDED, THAT EACH CREDITOR PARTY AND EACH COMPANY ACKNOWLEDGES
THAT ANY APPEALS FROM THOSE COURTS MAY HAVE TO BE HEARD BY A COURT LOCATED OUTSIDE OF THE COUNTY OF NEW YORK, STATE OF NEW YORK;
AND FURTHER PROVIDED, THAT, NOTHING IN THIS AGREEMENT SHALL BE DEEMED OR OPERATE TO PRECLUDE ANY CREDITOR PARTY FROM
BRINGING SUIT OR TAKING OTHER LEGAL ACTION IN ANY OTHER JURISDICTION IN WHICH ANY OF THE COLLATERAL IS LOCATED TO COLLECT THE LIABILITIES,
TO REALIZE ON THE COLLATERAL (AS DEFINED IN THE SECURITY AGREEMENT) OR ANY OTHER SECURITY FOR THE LIABILITIES, OR TO ENFORCE A
JUDGMENT OR OTHER COURT ORDER IN FAVOR OF ANY CREDITOR PARTY. EACH COMPANY EXPRESSLY SUBMITS AND CONSENTS IN ADVANCE TO SUCH JURISDICTION
IN ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURT, AND EACH COMPANY HEREBY WAIVES ANY OBJECTION THAT IT MAY HAVE BASED UPON LACK
OF PERSONAL JURISDICTION, IMPROPER VENUE OR FORUM NON CONVENIENS. EACH COMPANY HEREBY WAIVES PERSONAL SERVICE OF THE SUMMONS,
COMPLAINT AND OTHER PROCESS ISSUED IN ANY SUCH ACTION OR SUIT AND AGREES THAT SERVICE OF SUCH SUMMONS, COMPLAINT AND OTHER PROCESS
MAY BE MADE BY REGISTERED OR CERTIFIED MAIL ADDRESSED TO SUCH COMPANY AT THE ADDRESS SET FORTH IN SECTION 13.9 AND THAT SERVICE
SO MADE SHALL BE DEEMED COMPLETED UPON SUCH COMPANY’S ACTUAL RECEIPT THEREOF OR FIVE (5) BUSINESS DAYS AFTER DEPOSIT IN THE
U.S. MAIL, PROPER POSTAGE PREPAID.

 

(c)          THE
PARTIES DESIRE THAT THEIR DISPUTES BE RESOLVED BY A JUDGE APPLYING SUCH APPLICABLE LAWS. THEREFORE, TO ACHIEVE THE BEST COMBINATION
OF THE BENEFITS OF THE JUDICIAL SYSTEM AND/OR OF ARBITRATION, THE PARTIES HERETO WAIVE ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION,
SUIT, OR PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE, WHETHER ARISING IN CONTRACT, TORT, OR OTHERWISE BETWEEN ANY CREDITOR PARTY
AND/OR ANY COMPANY ARISING OUT OF, CONNECTED WITH, RELATED OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED BETWEEN THEM IN CONNECTION
WITH THIS AGREEMENT, ANY OTHER RELATED AGREEMENT OR THE TRANSACTIONS RELATED HERETO OR THERETO.

 

13.2        Severability.
Wherever possible each provision of this Agreement and the Related Agreements shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement or any Related Agreement shall be prohibited by or invalid
or illegal under applicable law such provision shall be ineffective to the extent of such prohibition or invalidity or illegality,
without invalidating the remainder of such provision or the remaining provisions thereof which shall not in any way be affected
or impaired thereby.

 

    	 	47	 

     

    

  

13.3        Independent
Nature of Purchasers. The obligations of each Purchaser hereunder are several and not joint with the obligations of any other
Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations of any other Purchaser hereunder.
Each Purchaser shall be responsible only for its own representations, warranties, agreements and covenants hereunder. The decision
of Purchaser to purchase the Notes pursuant to this Agreement has been made by such Purchaser independently of any other Purchaser
and independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties,
liabilities, results of operations, condition (financial or otherwise) or prospects of any Company or any of its Subsidiaries which
may have been made or given by any other Purchaser or by any agent or employee of any other Purchaser, and no Purchaser or any
of its agents or employees shall have any liability to any other Purchaser (or any other Person) relating to or arising from any
such information, materials, statements or opinions. Nothing contained herein, and no action taken by any Purchaser pursuant hereto
or thereto, shall be deemed to constitute Purchasers as a partnership, an association, a joint venture or any other kind of entity,
or create a presumption that Purchasers are in any way acting in concert or as a group with respect to such obligations or the
transactions contemplated hereby. Each Purchaser shall be entitled to independently protect and enforce its rights, including the
rights arising out of this Agreement, the Notes and the other Related Agreements, and it shall not be necessary for any other Purchaser
to be joined as an additional party in any proceeding for such purpose.

 

13.4        Survival,
Etc. The representations, warranties, covenants and agreements made herein shall survive any investigation made by any Creditor
Party and the closing of the transactions contemplated hereby. All statements as to factual matters contained in any certificate
or other instrument delivered by or on behalf of any Company pursuant hereto in connection with the transactions contemplated hereby
shall be deemed to be representations and warranties by such Company hereunder solely as of the date of such certificate or instrument.
All indemnities set forth herein shall survive the execution, delivery and termination of this Agreement and the Notes and the
making and repayment of the obligations arising hereunder, under the Notes and under the other Related Agreements.

 

13.5        Successors.

 

(a)          Except
as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors,
heirs, executors and administrators of the parties hereto and shall inure to the benefit of and be enforceable by each Person which
shall be a holder of any Note or Closing Shares from time to time, other than the holders of Common Stock which has been sold by
any Purchaser pursuant to Rule 144 or an effective registration statement. Each Creditor Party may assign any or all of the Liabilities
to any Person and, subject to acceptance and recordation thereof by Agent pursuant to Section 12.5 and receipt by Agent of a copy
of the agreement or instrument pursuant to which such assignment is made (each such agreement or instrument, an “Assignment
Agreement”), any such assignee shall succeed to all of such Creditor Party’s rights and obligations with respect
thereto. Upon such assignment, such Creditor Party shall be released from all responsibility for the Collateral. Each Creditor
Party may from time to time sell or otherwise grant participations in any of the Liabilities and the holder of any such participation
shall, subject to the terms of any agreement between such Creditor Party and such holder, be entitled to the same benefits as such
Creditor Party with respect to any security for the Liabilities in which such holder is a participant. Each Company agrees that
each such holder may exercise any and all rights of banker’s lien, set-off and counterclaim with respect to its participation
in the Liabilities as fully as though such Company were directly indebted to such holder in the amount of such participation. No
Company may assign any of its rights or obligations hereunder without the prior written consent of Agent. All of the terms, conditions,
promises, covenants, provisions and warranties of this Agreement shall inure to the benefit of each of the undersigned, and shall
bind the representatives, successors and permitted assigns of each Company.

 

    	 	48	 

     

    

  

(b)          Agent
shall maintain, or cause to be maintained, for this purpose only as agent of Companies, (i) a copy of each Assignment Agreement
delivered to it and (ii) a book entry system, within the meaning of U.S. Treasury Regulation Sections 15f.103-1(c) and 1.871-14(c)
(the “Register”), in which it will register the name and address of each Purchaser and the name and address
of each assignee of each Purchaser under this Agreement, and the principal amount of, and stated interest on, the Notes owing to
each such Purchaser and assignee pursuant to the terms hereof and each Assignment Agreement. The right, title and interest of Purchasers
and their assignees in and to such Notes shall be transferable only upon notation of such transfer in the Register, and no assignment
thereof shall be effective until recorded therein. Each Company and each Creditor Party shall treat each Person whose name is recorded
in the Register as a Purchaser pursuant to the terms hereof as a Purchaser and owner of an interest in the Liabilities hereunder
for all purposes of this Agreement, notwithstanding notice to the contrary or any notation of ownership or other writing or any
Notes. The Register shall be available for inspection by Companies or any Purchaser, at any reasonable time and from time to time,
upon reasonable prior notice.

 

13.6        Entire
Agreement; Maximum Interest. This Agreement, the Related Agreements, the exhibits
and schedules hereto and thereto and the other documents delivered pursuant hereto constitute the full and entire understanding
and agreement between the parties with regard to the subjects hereof. Nothing contained in this Agreement, any Related Agreement
or in any document referred to herein or delivered in connection herewith shall be deemed to establish or require the payment
of a rate of interest or other charges in excess of the maximum rate permitted by applicable law. In the event that the rate of
interest required to be paid or other charges hereunder exceed the maximum rate permitted by such law, any payments in excess
of such maximum shall be credited against amounts owed by Companies to Purchasers and thus refunded to Companies. Interest and
payments shall be computed on the basis of actual days elapsed in a year of 360 days.

 

13.7        Amendment
and Waiver.

 

(a)          This
Agreement may be amended or modified only upon the written consent of Companies and Agent.

 

(b)          The
obligations of Companies and the rights of the Creditor Parties under this Agreement may be waived only with the written consent
of Agent.

 

(c)          The
obligations of the Creditor Parties and the rights of Companies under this Agreement may be waived only with the written consent
of Companies.

 

    	 	49	 

     

    

  

13.8        Delays
or Omissions; Remedies. It is agreed that no delay or omission to exercise any
right, power or remedy accruing to any party, upon any breach, default or noncompliance by another party under this Agreement
or the Related Agreements, shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such
breach, default or noncompliance, or any acquiescence therein, or of or in any similar breach, default or noncompliance thereafter
occurring. All remedies, either under this Agreement or the Related Agreements, by law or otherwise afforded to any party, shall
be cumulative and not alternative. Purchasers and each holder of the Notes shall have all rights and remedies set forth herein
and in each Related Agreement and all rights and remedies that Purchasers and holders have been granted at any time under any
other agreement or contract and all of the rights that Purchasers and holders have under any law. Any Person having any rights
under any provision of this Agreement shall be entitled to enforce such rights specifically (without any requirement to post a
bond or other security or prove actual damages, which requirements each of the parties waives to the fullest extent permitted
by law), to recover damages by reason of any breach of any provision of this Agreement or any Related Agreement and to exercise
all other rights granted by law.

 

13.9        Notices.
All notices required or permitted hereunder or any Related Agreement shall be in writing and shall be deemed effectively given:

 

(a)          upon
personal delivery to the party to be notified;

 

(b)          when
sent by confirmed facsimile if sent during normal business hours of the recipient, or, if not, then on the next business day;

 

(c)          five
(5) business days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or

 

(d)          one
(1) business day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification
of receipt.

 

All communications shall
be sent as follows:

 

	If to any Company, to:	To the address indicated under its signature on the signature pages hereto
	 	 
	If to Agent, to:	To the address indicated under its signature on the signature pages hereto
	 	 
	If to a Purchaser:	To the address indicated under its signature on the signature pages hereto

 

or at such other address as any Company
or the applicable Creditor Party may designate by written notice to the other parties hereto given in accordance herewith.

 

13.10        Form
of Payment. Any Company hereby covenants, acknowledges and agrees that any payments to be made to any Purchaser pursuant to
this Agreement, the Notes or any Related Agreement shall be made by wire transfer of immediately available funds to such bank or
location as such Purchaser may direct in writing from time to time.

 

13.11        Attorneys’
Fees. In the event that any suit or action is instituted to enforce any provision
in this Agreement or any Related Agreement, the prevailing party in such dispute shall be entitled to recover from the losing
party all fees, costs and expenses of enforcing any right of such prevailing party under or with respect to this Agreement and/or
such Related Agreement, including such reasonable fees and expenses of attorneys and accountants, which shall include all fees,
costs and expenses of appeals.

 

    	 	50	 

     

    

  

13.12      Titles
and Subtitles. The titles of the sections and subsections of this Agreement are
for convenience of reference only and are not to be considered in construing this Agreement.

 

13.13      Signatures;
Counterparts. This Agreement may be executed by facsimile or electronic signatures
and in any number of counterparts, each of which shall be an original, but all of which together shall constitute one agreement.

 

13.14      Broker’s
Fees. Each party hereto represents and warrants that no agent, broker, investment
banker, person or firm acting on behalf of or under the authority of such party hereto is or will be entitled to any broker’s
or finder’s fee or any other commission directly or indirectly in connection with the transactions contemplated herein.
Each Company further agrees to indemnify each other party for any claims, losses or expenses incurred by such other party as a
result of the representation in this Section 13.14 being untrue.

 

13.15      Construction.
Each party acknowledges that its legal counsel participated in the preparation of this Agreement and the Related Agreements and,
therefore, stipulates that the rule of construction that ambiguities are to be resolved against the drafting party shall not be
applied in the interpretation of this Agreement or any Related Agreement to favor any party against the other. Unless the context
otherwise requires, (i) words in the singular or plural include the singular and plural and pronouns stated in either the masculine,
the feminine or neuter gender shall include the masculine, feminine and neuter, (ii) the words “hereof,” “herein”
and words to similar effect refer to this Agreement in its entirety, and (iii) the use of the word “including” in
this Agreement shall be by way of example rather than limitation.

 

13.16      Joint
and Several Obligations.

 

(a)          All
Liabilities (as defined below) of each Company to each Creditor Party shall be joint and several, and such obligations and liabilities
on the part of Companies shall in no way be affected by any extensions, renewals and forbearance granted by the Creditor Parties
to any Company, failure of the Creditor Parties to give any Company any notice, any failure of the Creditor Parties to pursue to
preserve its rights against any Company, the release by Agent of any collateral now or thereafter acquired from any Company, and
such agreement by any Company to pay upon any notice issued pursuant thereto is unconditional and unaffected by prior recourse
by any Creditor Party to any Company or any collateral for such Obligations or the lack thereof. As used in this Agreement, “Liabilities”
has the meaning given to such term in the Security Agreement.

 

(b)          Each
Company expressly waives any and all rights of subrogation, reimbursement, indemnity, exoneration, contribution or any other claim
which such Company may now or hereafter have against the other or other Person directly or contingently liable for the Obligations,
or against or with respect to any other’s property (including, without limitation, any property which is collateral for the
Obligations), arising from the existence or performance of this Agreement, until all Obligations have been indefeasibly paid in
full and this Agreement has been irrevocably terminated.

 

    	 	51	 

     

    

  

(c)          Each
Company represents and warrants to each Creditor Party that (i) such Companies have one or more common shareholders, directors
and officers, (ii) the businesses and corporate activities of Companies are closely related to, and substantially benefit, the
business and corporate activities of Companies, (iii) the financial and other operations of Companies are performed on a combined
basis as if Companies constituted a consolidated corporate group and (iv) Companies will receive a substantial economic benefit
from entering into this Agreement and will receive a substantial economic benefit from all amounts advanced by any Purchaser to
either Company in connection with the transactions contemplated hereby, in each case, whether or not such amount is used directly
by such Company.

 

13.17        Agency.
Each Purchaser has pursuant to an Administrative and Collateral Agency Agreement designated and appointed Agent as the administrative
and collateral agent of such Purchaser under this Agreement and the Related Agreements.

 

13.18        Costs
and Expenses. Companies jointly and severally agree to pay on demand, all costs and expenses of every kind incurred by any
Purchaser or Agent: (a) in enforcing this Agreement or any of the Related Agreements, (b) in collecting any of the Obligations
from any Company or any Guarantor, (c) in realizing upon or protecting or preserving any Collateral, and (d) in connection with
any amendment of, modification to, waiver or forbearance granted under, or enforcement or administration of this Agreement or any
of the Related Agreements or for any other purpose in connection with this Agreement or any of the Related Agreements, in each
case, to the extent any Purchaser or Agent may take such action pursuant to the terms and conditions of this Agreement or any of
the Related Agreements.  “Costs and expenses” as used in the preceding sentence shall include reasonable
attorneys’ fees incurred by any Purchaser or Agent in retaining legal counsel for advice, suit, appeal, any insolvency or
other proceedings under the U.S. Bankruptcy Code or otherwise, or for any purpose specified in the preceding sentence.

 

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY
LEFT BLANK]

 

    	 	52	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Note Purchase Agreement to be duly executed and delivered by their duly authorized officers
as of the date first set forth about.

 

	 	COMPANIES:
	 	 
	 	USELL.COM, INC.
	 	 	 
	 	By:	/s/ Nikhil Raman
	 	 	Name:  Nikhil Raman
	 	 	Title:    Chief Executive Officer
	 	 	 
	 	Address for Notices:
	 	 
	 	171 Madison Avenue, 17th Floor
	 	New York, New York  10016
	 	 
	 	BST DISTRIBUTION, INC.
	 	 	 
	 	By:	/s/ Brian Tepfer
	 	 	Name:  Brian Tepfer
	 	 	Title:    Chief Executive Officer
	 	 	 
	 	Address for Notices:
	 	 
	 	20 Nancy Street, Unit B
	 	West Babylon, NY 11704
	 	 
	 	WE SELL CELLULAR LLC
	 	 	 
	 	By:	/s/ Nikhil Raman
	 	 	Name:  Nikhil Raman
	 	 	Title:    Manager
	 	 	 
	 	Address for Notices:
	 	 
	 	20 Nancy Street, Unit B
	 	West Babylon, NY 11704

 

	 	 	SIGNATURE PAGE TO

NOTE PURCHASE AGREEMENT

 

     

     

    

  

	 	PURCHASERS:
	 	 
	 	Senior Health Insurance Company of Pennsylvania
	 	 	 
	 	By:	 /s/
	 	 	Name:
	 	 	Title:

 

	 	Address for Notices:
	 	 
	 	c/o B Asset Manager, LP
	 	1370 Avenue of the Americas, 32nd Floor
	 	New York, New York 10019
	 	Attn: Daniel Saks
	 	Facsimile: (212) 260-5051
	 	Email: dsaks@bassetmanager.com

 

	 	 	SIGNATURE PAGE TO

NOTE PURCHASE AGREEMENT

 

     

     

    

 

	 	AGENT:
	 	 
	 	BAM ADMINISTRATIVE SERVICES LLC
	 	 	 
	 	By:	 /s/
	 	 	Name:
	 	 	Title:

 

	 	Address for Notices:
	 	 
	 	c/o B Asset Manager, LP
	 	1370 Avenue of the Americas, 32nd Floor
	 	New York, New York 10019
	 	Attn: Daniel Saks
	 	Facsimile: (212) 260-5051
	 	Email: dsaks@bassetmanager.com
	 	 
	 	With a copy to:
	 	 
	 	Loeb & Loeb LLP
	 	345 Park Avenue
	 	New York, New York 10154
	 	Attn:  Scott J. Giordano, Esq.
	 	Facsimile:  (212) 504-2669
	 	Email:  sgiordano@loeb.com

 

	 	 	SIGNATURE PAGE TO

NOTE PURCHASE AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]